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Abstract
Susan Alderman, MSN, RN
Information Processing Speed Impairment after Stroke,
A descriptive study (IPS)
May, 2016
Cognitive impairment is any impairment of mental abilities and processes related to
knowing, specifically capacities for attending, remembering, and reasoning. Currently,
there is not a universally accepted model of cognitive recovery. An elemental cognitive
function, information processing speed (IPS) is defined as the time needed to complete a
cognitive task or the amount of cognitive work that can be done within a finite amount of
time. While there is agreement IPS is an essential function, there is no universally
agreement on how IPS interacts with other cognitive functions, how frequently IPS
becomes impaired, or the speed or magnitude of recovery. The aim of this study is to
describe the natural history, frequency, and severity of IPS impairment in patients with
recent mild to moderate stroke. A review of cognitive and self-care literature led to a
conceptual synthesis that defined patient-centered cognitive recovery in stroke (PCRS) as
a transitional state in which a person’s cognitive capacities can be modified by their
personal capabilities and resources to approach or achieve their pre-injury level of
cognitive health. As an essential cognitive function, the trajectory of spontaneous
recovery of IPS was observed to more fully understand IPS impairment. Pilot work
indicated IPS impairment in 97% of patients with acute stroke. Further, it indicated early
cognitive research could be performed within 72 hours of acute stroke and subjects were
able to complete the cognitive battery. In this exploratory study, cognitive measurements
for IPS and quality of life (QOL) questionnaires explored association between IPS
iv

impairment, stroke severity and QOL. Longitudinal data was obtained from 30 subjects
with mild or moderate stroke, at three time points. Analysis indicated frequency and
severity of IPS impairment was not associated of stroke severity and IPS impairment
persisted to the 90-day endpoint in 79% of subjects. A linear mixed model regression
indicated a relationship between IPS impairment and Applied Cognition Executive
Function QOL scores. Persistent IPS impairment, regardless of stroke severity, is
associated with poor QOL, demonstrating the need for a program of research to better
understand this essential cognitive function and its impact on cognitive recovery. An
exploratory evaluation of the adult short form Neuro-QOL as a unified scale was
performed; total score was the sum of the 13 short form domain scores. Independent
samples t-tests indicated the Neuro-QOL total score did not distinguishing between
subjects based on stroke severity but less severe IPS impairment was associated with
better QOL total scores. This preliminary evaluation encourages further research on a
totaled Neuro-QOL in this population.
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Summary of Study
This dissertation consists of two sections: the dissertation proposal in NIH format
with appendixes; and a manuscript entitled “Information Processing Speed after Stroke
(IPS), A Descriptive Study”. The manuscript presents findings from original research
approved by the Institutional Review Board on the University of Texas Health Science
Center at Houston.
The overall objective was to describe the natural history of IPS impairment,
namely its frequency, severity, and impact on quality of life (QOL) in acute to subacute
stroke, by stroke severity. The specific aims of the longitudinal research were to
determine the frequency and severity of IPS impairment in mild stroke and to evaluate
the association between severity of IPS impairment and QOL in survivors with mild
stroke compared to moderate stroke at 3 months.
The Patient-centered Cognitive Recovery in patients with Stroke (PCRS) model,
developed during a concept synthesis on cognitive recovery, guided this research. The
PCRS model defines cognitive recovery as a transitional state in which a person’s
cognitive capacities can be modified by personal capabilities and environments to
approach or achieve the person’s pre-injury level of cognitive health. An elemental
cognitive function, information processing speed, has been identified as hindering
performance of other cognitive functions such as memory, attention and executive
function. Therefore, a better understanding of IPS impairment presentation and
spontaneous recovery was needed; before an intervention to improve IPS function can be
instituted. This study observed changes in IPS and memory during the acute and subacute
phase of cognitive recovery and evaluated the impact of IPS impairment on QOL.
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The initial pilot work on this study involved 10 subjects and focused on the
feasibility of performing cognitive research in the acute setting. The dearth of acute phase
cognitive research required performance of a pilot study to verify adequate availability of
subjects with mild or moderate stroke, a significant amount of subjects could complete
the cognitive testing, and subjects would not be negatively impacted by the burden of
cognitive testing during their acute recovery phase. This phase of research indicated the
protocol was adequate to provide sufficient data to answer the research questions and the
study was continued.
The next phase of the research involved repeating cognitive testing in up to 30
subjects at two additional time points, three weeks and twelve weeks after stroke. A
total of 42 subjects were enrolled and completed the baseline or in hospital visit.
However, 12 subjects did not complete the three study visits and their data was not
included in analysis.
Hospital patient census for the UT stroke service were screened daily for eligible
patients. Based on medical records and discussions with healthcare providers, eligible
patients were approached for a consent discussion. Prior to enrollment, a proxy, either
family member or friend, verified an absence of pre-existing cognitive impairment and
the potential subject was administered the Symbol Digit Modalities Test (SDMT). If the
subject failed the SDMT, they were invited to participate. Multiple settings were used to
perform the study. The initial visit was performed while the subject was admitted for
acute stroke at the Memorial Hermann-TMC hospital. The two follow up visits were
performed at testing centers, inpatient units, or at the subject’s residence. Strict safety
procedures were followed to ensure safety of the investigator when testing was performed
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in subjects’ residences; including pre and post telephone calls to a monitor and use of a
safety phrase at completion of each visit.
Collected data was transcribed to a case report form and tabulated onto an excel
spread sheet. Once collected, 100% of the data was evaluated for quality of transcribed
and tabulated data. Data analysis was performed by a statistician under the supervision of
the investigator. Descriptive statistics were used to describe the sample. Independent ttests indicated changes in frequency and severity of IPS impairment. Linear mixed
method regression was used to determine lack of relationship between IPS impairment
and stroke severity. Mixed methods did indicate a relationship between IPS impairment
and poor QOL in relationship to executive function. These results are described in the
manuscript, “Information Processing Speed Impairment after Stroke, A Descriptive
Study”. This study is a preliminary step in a program of research to understand cognitive
recovery after stroke. The planned research program will focus on factors that impede
cognitive recovery and the testing of interventions to speed cognitive recovery.
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Introduction
In 2010, there were seven million survivors of stroke in the USA (Center for
Disease Control, 2013) with 65% developing cognitive impairments after stroke. With
the current 3% prevalence of stroke there will be 13 million survivors of stroke in 2030
and 8.5 million of them will develop cognitive impairments (CI) (Rogers et al., 2011).
For newly impaired survivors, 70% suffer from information processing speed (IPS)
impairment; a particular cognitive impairment that will likely persist regardless of routine
rehabilitation care (Lesniak, Bak, Czepiel, Seniow & Czlonkowska, 2008). IPS
impairment slows the ability to process information, impacting instrumental activities of
daily living (IADL), such as the ability to make decisions, understand conversations, pay
bills, cook, or drive a car (Winkens, 2009). IPS impairment becomes most apparent after
the discharge home, when patients frequently expect to function at a pre-stroke level. The
seminal work by Salthouse (1996) indicated the impairment would be most noticeable
during activities which are new to the patient or have an element of time pressure with a
need for continuous and conscious processing of information. A clearer understanding
of IPS impairment in acute stroke is required to identify treatment and improve quality of
life. Little research has been done regarding IPS impairment after stroke and none related
to IPS impairment progression in acute to sub-acute stroke, specifically the period up to
three months after a stroke. Specific measurements for cognitive assessment are not
routinely performed on the acute stroke population. Survivors of mild stroke, in
particular, are discharged with limited rehabilitation, on the assumption that the stroke
will have minimal residual effect.
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The purpose of this observational study is to describe the natural history,
frequency, and severity of IPS impairment in patients with recent mild to moderate
stroke. The primary hypothesis of the study is that people with new mild strokes will
experience IPS impairment at an equal or greater rate than those identified by Lesnik et
al. (2008), in the overall stroke population. Additionally, IPS impairment will affect
quality of life regardless of routine rehabilitation care. The results of this study will help
in better understanding the feasibility of early IPS testing after stroke, if IPS impairment
is associated with stroke severity and whether impaired IPS immediately after an
ischemic stroke improves with routine acute and rehabilitation care. Determining the
severity of IPS impairment in mild as well as moderate stroke will impact a significant
amount of undertreated people. A well-supported understanding of how it presents is
necessary before we can begin to formulate effective treatments.
Specific Aims
Specific Aim 1: To determine the frequency and severity of IPS impairment, as
evidenced by abnormal Symbol Digit Modalities Test (SDMT) values, in mild stroke
(NIHSS < 5) compared to moderate stroke (NIHSS >5) at three time points.
Hypothesis: The rate of frequency and severity of IPS impairment will be similar
in mild and moderate stroke at each time point, < 72 hours, 3 weeks and 12 weeks post
stroke, as demonstrated by a medium effect size. Abnormal SDMT scores are: male a
written score less than 51 (oral: < 61) and female a written score less than 54 (oral: < 62).
Specific Aim 2: To evaluate the association between severity of IPS impairment and
quality of life in mild stroke (NIHSS < 5) compared to moderate stroke (NIHSS >5)
survivors at 3 months.
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Hypothesis: There will be a significant correlation between severity of IPS
impairment and quality of life indicators, independent of stroke-severity group
membership.
Specific Aim 3: To evaluate the correlation between IPS impairment and four
subsections of the Neuro-QOL compared to the overall Neuro-QOL score in mild
survivors of stroke at 3 months.
Hypothesis: There will be a significant correlation between IPS impairment in
mild stroke and subsections of the Neuro-QOL (Depression, Applied Cognition-general
concerns, Applied Cognition-Executive Function and Positive Affect & Well-Being)
when compared to the overall Neuro-QOL score.
Background and Significance
The proposed project is significant in that several knowledge gaps will be
addressed:


Patients with mild to moderate strokes can be impacted by unrecognized IPS
impairment.
o The frequency of IPS impairment is unknown in acute to sub-acute stroke.
o It is unknown if patients with moderate stroke experience more severe IPS
impairment than patients with mild stroke.



Untreated IPS impairment in patients with mild to moderate strokes can seriously
impact IADLs and quality of life (QOL).
o It is unknown if patients with mild stroke experience a significant
reduction in QOL in association with IPS impairment
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o The overall score of common post-stroke QOL measurement, Neuro-QOL,
may not accurately reflect quality of life in patients with mild stroke.


An understanding of the natural history of IPS impairment in acute to sub-acute
stroke is necessary before research in QOL measurements or IPS treatment can be
initiated.



An understanding of IPS impairment severity in patients with mild stroke may
stimulate research into defining criteria for acute medical treatment and
rehabilitation.

Specific Aim 1 Knowledge Gap: IPS impairment and stroke severity
If processing speed is a fundamental component of the architecture of cognition as
Kail and Salthouse (1994) suggest then it is important to evaluate IPS impairment in
stroke based on three factors: IPS impairment theory, IPS and stroke severity, and
recovery time. Little research has been completed on IPS impairment after mild acute
stroke. Typically, research endpoints for cognitive impairment after mild stroke start at
between 3-12 months’ post stroke (Makin, Turpin, Dennis & Wardlaw, 2013). In Lesniak
et al. (2008) IPS impairment was identified in 70% of patients at the first study contact,
three months’ post stroke. But preliminary work on the current study indicates IPS
impairment after acute stroke may be 100% (see Preliminary Study: Summary of results).
IPS impairment theory.
Most information on IPS changes comes from research on aging and degenerative
diseases such as multiple sclerosis (Chiaravalloti & DeLuca, 2008; Rebok et al., 2014).
Treating IPS impairment in stroke must begin with defining it and understanding the
mechanism of impairment. Martin & Bush (2008) defined IPS as the time required to
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execute a cognitive task or the amount of work that can be completed within a finite
period of time. It may be a mediating agent between working memory and executive
function (Jobe et al., 2001), increasing the efficiency of our ability to perform critical
specialized and common activities of daily living. Salthouse (1996) determined two
mechanisms can affect processing speed, the Limited Time and Simultaneity
mechanisms.
In the first mechanism, Limited Time, the injured brain takes longer to perform
multi-step or complex tasks because the time needed to perform later-step operations
continues to be used in the execution of early-step operations. This problem is most
noticeable when there are external time pressures and the patient executes information
processing too slowly to complete a task in given amount of time (Winkens, 2009). For
example, a person does not apply the brakes on a car before running a stop sign because
of extended time required to process information (sign recognition). This leads to failure
to recognize a stop sign and take action within the necessary time limit.
In the second mechanism, Simultaneity, “information decreases in availability
over time as a function of decay or displacement…the products of early processing may
be lost or may have become inaccurate before later processing is ready to use it”
(Winkens, 2009). Processing impairment becomes apparent when slow IPS results in
displaced (lost) or inaccurate low-level information affecting higher-order cognitive
processes. For example, extended processing time is used to understand lower-order
information such as sign identification and the distance to the stop sign. By the time the
patient has moved onto a higher order processing step, e.g. calculating how much braking
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pressure to apply to ensure appropriate stopping, the distance information has decayed or
been lost from short term memory.
Stroke severity and IPS impairment.
Stroke severity is defined by severity of impairment, as indicated by a range of 042 points, on the National Institute of Health Stroke Scale (NIHSS). A mild stroke has a
NIHSS of <5 (Smith et al., 2005) and moderate stroke score is 6-12. Typically, patients
with stroke are not treated with thrombolytic unless their National Institute of Health
Stroke Scale (NIHSS) is moderately elevated (>5), even if the patient presents early
enough for treatment (Smith et al., 2005). Survivors of moderate stroke frequently have
severe motor impairment including hemiplegia, aphasia, visual impairment or neglect.
Mild survivors of stroke usually have no or minimal motor dysfunction, such as
numbness, minor arm weakness, mild facial drooping or dysarthria.
Lacking obviously debilitating physical impairments, patients with mild stroke
(NIHSS < 5) may be experiencing inequity in healthcare. Mild survivors of stroke are
often sent home after a short admission without significant rehabilitation or social
adjustments because, per NIHSS criterion, they appear to be minimally effected by their
stroke. However, the NIHSS, used to determine medical treatment, is not designed to
measure cognition (Balucani & Levine, 2011).
Few survivors of stroke receive IPS assessment in the acute or sub-acute recovery
phase. It has been assumed that a mild stroke leaves less residual cognitive impairments
but research indicates that may not be accurate. Edwards et al. (2006) indicated 62% of
patients with mild strokes were unable to return to work or previous other activities
despite returning to full physical independence. IPS impairment affects every aspect of
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our daily life including the ability to think clearly, make decisions, understand
conversations, or driving a car. Early detection and treatment of impairment can slow or
halt brain degeneration and improve outcomes (Al-Qazzaz et al., 2014).
Recovery time.
Another factor to be considered in IPS evaluation is recovery time.
Neuroplasticity is a brain recovery process with a relatively flexible 1 to 4-week time
window; certain conditions such as physical therapy (PT) may keep it open longer
(Murphy & Corbett, 2009). Their animal studies indicate the optimal neuroplasticity
window might expand for the injured brain, even as far out as 8 weeks. Neuroplasticity
changes occur in respect to increased demands made on the brain during challenging
physical or cognitive activities. Further, these studies indicate brain remodeling begins
within days of brain injury, with a neuronal hyper-excitability period encouraging axonal
growth occurring 1-3 days after stroke (Murphy& Corbett, 2009). Additional animal
studies indicate the ideal period to begin to relearn lost skills is within 5 days after a
stroke, when the brain is remodeling its neural circuitry, encoding new experiences, and
enabling behavioral and functional changes (Biernaskie, Chernenko & Corbett, 2004:
Kleim & Jones, 2008).
Some patients with mild to moderate strokes receive PT while others return home,
without rehabilitation, and attempt to resume their previous lifestyle. Specific
assessments for cognitive function are not routinely performed in acute stroke
(Gottesman & Hillis, 2010) with little research beginning earlier than one-month post
stroke. If a simple quick IPS assessment can be performed in the acute stage, then clinical
treatment can be instituted for cognitive or functional impairment.
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Specific Aim 2 Knowledge Gap: impact of stroke severity and IPS impairment on
quality of life
Despite minimal motor impairment in mild strokes, complaints of poor quality of
life may persist long after the stroke event. Carlsson, Moller & Blomstrand (2009) noted
that few people with mild strokes were able to return to full time employment and 60%
rated their quality of life as not good. Patients, with mild stroke, report persistent
symptoms at three months including poor outcomes on disability scales (29%) (Edwards
et al, 2006), decreased ability in employment activities (62%), decreased social activity
(36%), and are less able to drive (18%) compared to before their stroke (Nedeltchev et al,
2007; Smith et al, 2011). For this study it is hypothesized that cognitive impairment,
rather than physical consequences, results in the radical changes in the lives of mild stoke
survivors.
Specific Aim 3 Knowledge Gap: correlation of IPS impairment to quality of life
(QOL) sub-scales
Information gained from any trial depends on the quality of instruments
measuring the data. The Stroke Specific Quality of Life scale (SS-QOL) and Neuro-QOL
scale have undergone sufficient analysis to indicate that they are acceptable instruments
to measure QOL in the general stroke population (Lai, Studenski, Duncan, & Perera,
2002; Perez et al., 2007). But both instruments dedicate significant weight to motor
function items, which may not be impacted in mild stroke survivors. In general, these
scales may not accurately measure QOL in patients with stroke with predominatelycognitive impairments. To assess QOL specifically in this population, those Neuro-QOL
subsections most impacted by cognitive impairment will be compared to the overall
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Neuro-QOL score. The pertinent Neuro-QOL subsections include Depression, Applied
Cognition-general concerns, Applied Cognition-Executive Function and Positive Affect
& Well-Being. The additional subsections include Anxiety, Fatigue, Sleep Disturbance,
Participation in social roles, Satisfaction in social roles, Stigma, Upper and Lower body
function.
Preliminary Study
Purpose.
A preliminary study was done to determine the feasibility of IPS testing after
acute stroke and to determine if there were indications of an association between IPS
impairment and stroke severity. The preliminary study also identified logistical and
clinical challenges of cognitive testing within 72 hours of stroke.
Summary of Results.
Patients admitted to the Stroke Service (N=163) at a tertiary hospital were
screened from 10/8/14 to 11/21/14. Ten subjects (6%) were qualified, enrolled, and
assessed (see Table 1). Four preliminary study subjects (40%) had moderate strokes
(NIHSS >6). Five criteria accounted for 83% of exclusion criteria and included: brain
hemorrhage (n= 39), Age >80 (n=29), NIHSS > 12 (n=27), not a stroke (n=24), stroke
onset > 72 hours (n=16). The intent of the study is to assess IPS impairment in patients
with mild and moderate acute stroke therefore enrollment was limited to subjects with
acute ischemic strokes with a NIHSS < 12. Treatment, complications and recovery for
patients with hemorrhagic stroke or severe ischemic stroke can be different than in mild
to moderate ischemic stroke; adding variables to the study which may confound
comparisons between mild and moderate stroke. The age limit excludes patients older
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than 80 years to avoid natural slowing with age confounding results. A stroke onset of
greater than 72 hours was excluded in order to capture IPS status before brain structure
changes occurred, according to neuroplasticity theory (Murphy & Corbett, 2009).

All ten subjects in the feasibility study failed the SDMT, indicating IPS
impairment. Therefore, there are a sufficient percentage of patients with IPS impairment
to warrant continued study. Compared to the SDMT normative score table, the averaged
Standard Deviation (SD) of less than 2 SD falls into the very low score category (Smith,
2013). The hypothesis that moderate stroke would be more likely to fail the SDMT was
rejected. (p= 0.99).
To determine if an assessment can be completed within the required time span,
the time from symptom onset was compared to time of testing. All subjects were able to
undergo study testing within 72 hours of stroke symptom onset (Mean 47.5 hours, SD
0.31, time range 31-65 hours). All subjects completed testing within approximately 30
minutes. Sufficient information from the feasibility study indicates that it is possible to
perform cognitive research during the acute phase after stroke.
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A sample of 10 subjects is likely too small to make a truly valid determination
regarding accepting or rejecting a hypothesis. However, it may give indications that are
of interest to an investigator. The NIHSS’ were statistically significantly different
between the mild and moderate stroke subjects in this sample (p=0.0008). But none of the
cognitive assessments indicated a significant difference based on stroke severity (see
Table 2), indicating both mild and moderate survivors of stroke may suffer from similar
IPS impairments.

This lack of significant difference may indicate that cognitive impairment is not
based on stroke severity; contradicting the assumption that patients with mild stroke are
not significantly impacted by their stroke. If so, patients with a low NIHSS but
undiagnosed cognitive impairments are being under treated in the acute setting. Patients
with mild stroke may benefit from t-PA administration, even though they have only
minor motor dysfunction. Additionally, there was no significant difference in time of
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symptom onset to assessment between the mild and moderate stroke groups (p=0.99).
This indicates that the moderate stroke subjects did not require additional resting time
before assessment.
Innovation
There has been no research on IPS impairment frequency or severity in survivors
of acute stroke, if stroke severity impacts IPS severity or if IPS stabilizes or worsens over
the first few months’ post stroke. The innovative study objectives include:


The study design uses SDMT and PSI to categorize IPS impairment severity in
acute and sub-acute mild & moderate stroke, filling a current gap in knowledge.



Specifically identifying IPS impairment in mild compared to moderate stroke can
encourage a change in stroke treatment for mild strokes by indicating that they are
currently an undertreated population.



Success in this project will identify IPS impairment as a reason for poor quality of
life in patients with mild stroke.



This project will provide much needed information on two common QOL
instruments and their adequacy for assessment in patients with mild stroke. This
will lay a foundation for further research and creation of a QOL instrument
specifically for patients with mild stroke or TIA.



Applying neuroplasticity time-window principles, the study’s post stroke time
points of <72 hours, 3 weeks and 12 weeks correlate the IPS recovery period to
the timing of neuroplasticity changes, leading to future research on early
neurocognitive assessment and on IPS impairment interventions.
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Approach Section
Overview
This is a prospective, longitudinal observational study of 30 subjects in two groups (mild
and moderate acute ischemic stroke). The purpose of the study is to describe the natural
history, frequency and severity of IPS impairment in the acute and sub-acute periods after
recent mild or moderate stroke. Subjects with strokes will be assigned to the mild or the
moderate group, with approximately 50% of subjects as mild (NIHSS <5) (n=15) and
50% (n=15) moderate (NIHSS > 5). A number count will be kept for the duration of the
study so that prevalence calculations can be performed on all persons approached for the
study.
A pilot study was performed focusing on feasibility and prevalence of IPS
impairment in mild to moderate stroke. A convenience sample of 10 patients, admitted
with stroke and meeting inclusion/exclusion criteria (except SDMT as a screening score),
participated in the study. Subjects in the pilot study did not have the SDMT assessment
until after enrollment to protect against bias related to prevalence calculations. At the
completion of the preliminary study it was noted that all 10 subjects had IPS impairment
and were eligible to complete all three study visit time points. Therefore, all pilot study
subjects have dual participation in the overall dissertation study. Their presence in the
pilot study will relate to study feasibility and prevalence of IPS impairment and their
participation in the larger study will be as IPS impaired subjects in the natural history
study.
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Study Design and Methods
Study Population.
To participate, subjects must meet the following inclusion criteria: have a
diagnosis of acute ischemic stroke identified by clinical exam, CT or MRI done as
standard of care, Age ≥ 18 and < 80 years old, NIHSS < 12 for left hemispheric stroke
and < 10 for right hemispheric stroke, and abnormal screening SDMT scores. Subjects
will be not be enrolled if any of the following exclusion criteria are identified: if they
have any prior neurological, psychiatric or physical disorder which might confound
testing, such as brain cancer, neurodegenerative disorders, blindness, severe depression or
schizophrenia; if the NIHSS 1a (level of consciousness) is > 0; unable to complete follow
up visits; or are unable to converse in English language with ease (dysarthria and mild
aphasia allowed i.e. NIHSS 9 and 10 scores <1). A database will be updated daily,
indicating exclusion criteria, and will be used to inform future study design and possible
enrollment bias.
Recruitment and Retention
Study subjects will be enrolled and undergo the baseline visit at a Comprehensive
Stroke Center located in Houston, Texas and the two follow up visits will be done at a
quiet place the subject selects or at the University of Texas Nursing School Center for
Nursing Research. Approximately 100 patients with ischemic and hemorrhagic stroke are
admitted monthly at this hospital. The study PI has full access to the study population
through a relationship with the treating neurology group.
Potential subjects will be approached at any time within 72 hours of the stroke
symptom onset. This time period was selected because it matches the acute stroke
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treatment phase. The nearer to the time of onset is preferred but testing must not
interfere with acute treatment. With the subject’s permission, the consent process will
include discussions with available family, at the subject’s bedside or by phone as
necessary. Family involvement is a key to retention in stroke research (Hadidi,
Buckwalter, Lindquist, & Rangen, 2012). Subject retention will be facilitated by periodic
phone calls, reminder post cards and by creating an environment of cooperation and buyin from the subject and family at the baseline visit. The investigator’s contact information
is given to the subject and available family and they are encouraged to have friends or
family call with any questions. Retention strategies also included payment of a $40.00
subject stipend, to cover subject travel expenses and presenting subjects and families with
multiple options for follow up visit locations, including the investigator traveling to the
subject’s home. Lost to follow up rate of retention for the pilot study was 12%.
Research Subject Risk and Protection
The protocol and proposed consent was approved by the University of TexasHouston Committee for the Protection of Human Subjects (CPHS) and the Memorial
Hermann Hospital Research Office. The protocol includes strict inclusion and exclusion
criteria which will not exclude subjects based on race or gender but will limit age due to
increased likelihood of cognitive effects of normal brain aging. The consent form will be
reviewed to ensure that language is at the fifth grade reading level. After a thorough
explanation of the risks and benefits by a member of the research team, consent will be
obtained from the subject or LAR. Adequate time to read and ask questions will be given
to the subject. Additionally, if the subject becomes fatigued during testing a short break
will occur and length of break will be noted on the source documents. There are no

20

known risks for cognitive testing and an explanation of cognitive impairments, IPS
impairment in particular, is given to the subject and available family. Subject and family
are encouraged to discuss concerns about the subject’s cognitive status and possible
recovery trajectories. The subject and family are made aware that the results of testing
will be discussed after the week 12 evaluation and further suggestions will be given to the
subject, including the suggestion to contact the neurologists for additional evaluation and
possible referral to a neuropsychologist. All data will be protected to the full extent of the
law by use of a de-identifying code; password protected computers and double locked
cabinets.
Data Plan
Measurements:
Six paper and pencil cognitive instruments are completed by the subject within a
30 minutes’ time-period; the instruments are three measuring IPS (SDMT, DSC, and
Symbol Search), two measuring memory (CVLT II SF and Digit Span), and the MoCA
which measure multiple cognitive domains.

The instruments administered in sequential

order are the CVLT (immediate and short delay trials), SDMT, DSC, Symbol Search,
Digit Span, CVLT long-delay trial, and MoCA.
A break between tests can be taken without interfering with testing, with the
exception of the CVLT long-delay. A 15-25 minutes’ interval between the short and long
delay trials is acceptable (Delis, 2000). If the break time extends beyond 25 minutes, then
the alternate CVLT form will be used when testing recommences. The order of tests
enables the IPS tests to be done relatively early in the testing period, before potential
fatigue occurs.
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To decrease likelihood of practice effect there are three weeks between the
baseline testing and Week 3 visit and nine weeks between the Week 3 and the Week 12
visit. Practice effect on cognitive instruments is noted on high frequency testing but not
on low frequency testing (Falleti, Maruff, Collie, & Darby, 2006). High frequency
testing is repeatedly administering the testing battery several times at 10-minute intervals.
Low frequency testing would include a weeks or months long time intervals between a
single administering of the battery. No significant practice effect was noted on the
SDMT (Smith, 2013) or the MoCA (Costa et al., 2012) at any time interval. No
significant practice effect was noted on the DSC, Symbol Search, or the Digit Span at the
four-week intervals (Strauss, Sherman and Spreen, 2006).

The CVLT-II short form has

a negligible practice effect at a four-week time intervals between testing (Woods, Delis,
Scott, Kramer, & Holdnack, 2006).
Two quality of life instruments are completed by the subject at the 12 Week visit. As
part of subject history, the IQCODE will be completed by a proxy who has known the
subject for five years prior to baseline visit. A description of each instrument is included
below.


California Verbal Learning test– 2nd Ed. Short form (CVLT-II SF): The
subject is asked to learn and remember a short list of words (9-words) with four
immediate and two delayed recalls (5 and 10 minutes apart). For the immediate
recall trials, the subject is read the word list and asked to repeat the words
immediately after each of 4 list readings. Then a short delay (about 5 min) occurs
while the other cognitive tests are performed. After the short delay the subject is
asked to recall the list, i.e. the short delay test. Afterward additional activities
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(other cognitive tests) are performed and 10 minutes later the subject is asked to
recall the list again, i.e. the long delay test. Delis et al. (2000) evaluated the
CVLT II for split-half and word category reliability and show Cronbach’s alpha
of 0.96 and 0.83 respectively with adequate test-retest reliability for a median
time interval of 3 weeks. Evidence of validity was indicated for the CVLT II by
factor analysis showing the same six factor analysis as occurred with the original
CVLT. Scoring and interpretation information was obtained from Delis, Kramer,
Kaplan, & Ober (2000).
o Scoring: 1 point for each correctly recalled word from the word list.
Scoring performed on CVLT licensed software, comparing subject raw
score results to normative data and converted to z-score.
o Interpretation: In Trial 4, Short, and Long Delay Trials: z score of zero is
average with (+/-) 0.3 to1 score reflects the above/below average recall or
retention rate. Trial 4 indicates the level of recall; the Short and Long
delay trials test durability of memory. Both Short and Long z-scores
should be similar indicating no variable attention problem. In subcortical
stroke there may be a deficit in level of recall but a more normal retention
rate.


Digit Span: The Digit Span is a WAIS III subtest indicating working memory
impairment. It tests immediate recall, reversibility, ability to shift thought
patterns, concentration and attention. For Digit Span Forward, the subject is read
a series of numbers and recalls the numbers in the same order. For Digit Span
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Backward, the subject is read a series of numbers and recalls the numbers in
reverse order.
o Scoring: 1 point for each set of digits properly recalled. Testing stops
after two failures of the same digit length. Maximum score is 30 points.
Scoring follows Wechsler Classification range: The normative table
converts the raw score to a standard score. If the standard score is 10 then
the z-score is 0. For each increase or decrease of 1 point in standard score,
z-score goes up or down by 0.33. For example, standard score of 13 = zscore of 1.0. (Wechsler, 1997).
o Interpretation: Wechsler’s Classification Range (standard score):
Extremely Low (1-4), Unusually low (5-6), Low Average (7), Average (812), High Average (13), Superior (14-15), Very Superior (16-19) (Brooks,
Sherman, Iverson, Slick, & Strauss, 2011).


Digit Symbol – Coding (DSC): The DSC involves a simple substitution task
using a reference key. The subject has 120 seconds to pair specific geometric
figures with given numbers, drawing the figures in the box of the matching
number (Tulsky, Saklofske, & Zhu, 2003). The DSC specifically informs on
perception and graphomotor speed therefore poor performance, when compared to
the SDMT and the Symbol Search, may inform on motor as well as cognitive
impairment (Strauss et al., 2006).
o Scoring: 1 point for each figure properly drawn. Maximum score is 133
points. Follows Wechsler Classification range scoring (Wechsler, 1997).
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o Interpretation: Follows Wechsler’s Classification Range (standard score)
(Brooks et al., 2011).


Informant Questionnaire on Cognitive Decline – Short Form (IQCODE-SF) is
completed by a proxy who has known the subject for five years prior to the stroke.
It will indicate if the subject has had a cognitive decline prior to the stroke. The
16 item IQCODE-SF has a 0.98 correlation with the full 26 item form,
Cronbach’s alpha 0.97, a sensitivity of 73% for vascular dementia and has been
found to predict dementia in patients with stroke at 3 years’ post-stroke (Jorm,
2004).
o Scoring: scored on a Likert scale of 1-5 ranging from Much Improved (1)
to Much Worse (5). All item scores should be three or below.
o Interpretation: A score of 4-5 indicates dementia, signifying the subject
has a history of cognitive impairment over the five years prior to the
stroke.



MoCA: The Montreal Cognitive Assessment assesses cognitive domains of
attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation.
Nasreddine et al. (2005) examined the internal consistency of the MoCA and
reported a Cronbach's alpha (alpha = 0.83). The test-retest reliability correlation
between the two evaluations was r = 0.92. Nasreddine et al. (2005) the MoCA
indicate concurrent validity by correlation between the MoCA and the MMSE (r =
0.87).
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o Scoring: Scoring: Each of the ten items can score 1-6 points. Maximum
score of 30. The average score for all ages is 27.4 with a standard
deviation of 2.2. Add a point to the subject’s raw score if they have ≤ 12
years of education and then subtract the average score (27.4) from the raw
score. Divide that difference by 2.2 and the result is the z-score.
o Interpretation: Add one point for subjects with 12 or less years of
education. A final score of 26 or above is considered normal. A final score
of less than 26 indicates cognitive impairment (Canadian Partnership for
Stroke Recovery, 2015).


Neuro-QOL: Neuro-QOL is a set of self-report measures that assesses the healthrelated quality of life (HRQOL) of adults and children with neurological
disorders. Neuro-QOL is comprised of item banks and scales that evaluate
symptoms, concerns, and issues that are relevant across disorders (generic
measures) and can be given as a fixed-length short form. The Neuro-QOL
instruments enable within-disease as well as cross-disease comparisons and are
intended for use in both neurology clinical trials and clinical practice. Scoring and
interpretation was obtained from National Institute of Neurological Disorders and
Stroke (NINDS) website (2010) and the Neuro-QOL Assessment Center (2015).
o Scoring: Scoring: Sum total responses from 13 sections (domains) 5-point
Likert scale, responses range from a very positive to a very negative.
Maximum score of 525.
o Interpretation: Using the NINDS manual conversion table, the raw scores
are converted to t-scores. No standardized or normative values available
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for comparison; high score indicates either worse (undesirable) or better
(desirable) QOL, depending on domain of interest, with a high overall
score indicating a better (desirable) QOL.


SDMT: Both a screening tool to determine eligibility and is a primary outcome
variable. The SDMT involves a simple substitution task using a reference key.
The subject has 60 seconds to pair a number with a given specific geometric
figure, writing the numbers in the box of the matching figure. The SDMT
involves a simple substitution task designed to assess attention, visual scanning,
and motor and psychomotor speed. Because subjects can give written or spoken
responses, the test can be used in motor disabilities or speech disorders (Sheridan
et al., 2006). Reliability for three alternate forms demonstrated at r > .80. There is
a high correlation for validity (0.88) in patients with head injury. Because SDMT
involves only geometric figures and numbers, it is relatively culture bias free. It
shows high correlation for processing speed and is extremely sensitive in brain
insult (Strauss, Sherman, E. & Spreen, 2006). Felmingham, Baguley, and Green et
al., (2004) indicates it is particularly sensitive to the cognitive effects of diffuse
axonal injury in traumatic brain injury (TBI). The SDMT is considered a “purer”
measurement of IPS than other processing speed tests (Martin & Bush, 2008) and
is the single best indicator of information processing impairment in patients with
TBI (Ponsford & Kinsella, 1992). The SDMT has been used to evaluate IPS in
TBI, Alzheimer’s and multiple sclerosis. This study is novel in the use of the
SDMT to evaluate IPS impairment in patients with stroke. Scoring and
interpretation was obtained from the SDMT manual (Smith, 2013)

27

o Scoring: 1 point for each number correctly matched to presented figures.
Maximum score is 110. The raw score is converted to a z-score using the
SDMT Manual (Table 3) based on education level (≤ 12 years or ≥ 13
years).
o Interpretation: Scores are ranged by SD for a particular age group at a
particular education level; one SD can range from 7.98- 13.54 points,
depending on age. Low scores are approximately 1 SD (7.98- 13.54)
below mean, Moderately Low scores are approximately 1.5 SD below
mean, Very Low scores are approximately 2 SD below mean.


SS-QOL: The Stroke Specific Quality Of Life scale (SS-QOL) is a patientcentered outcome measure intended to provide an assessment of health-related
quality of life specific to patients with stroke. It measures stroke specific changes
in quality of life for individuals who have had a stroke. This evaluation consists of
49 items that focus on 12 areas of health-related quality of life. The areas include
the following: energy, family roles, language, mobility, mood, personality, selfcare, social roles, thinking, vision, upper-extremity function and work
productivity
o Scoring: Scale contains 49 items in 12 domains on a 5-point Likert scale,
responses range from a very positive to a very negative. Maximum score
of 245.
o Interpretation: No standardized or normative values available for
comparison; higher score indicates better function in both domain and
overall summary score.

28



Symbol Search: The Symbol Search is a WAIS III subtest indicating information
processing speed. It tests speed of visual search, speed of processing information,
planning, encoding information in preparation for further processing, visuo-motor
coordination and learning ability. The subject has 120 seconds, using the Symbol
search booklet, to scan several rows of symbols and on each row indicates
whether one of the symbols in the small target group matches a symbol in a larger
search group.
o Scoring: 1 point for each correct answer per row. Subtract the total
number of incorrect responses from the total number of correct responses.
Maximum score is 60 points. Follows Wechsler Classification range
scoring (Wechsler, 1997).
o Interpretation: Follows Wechsler’s Classification Range (standard score)
(Brooks et al., 2011).

Data Collection
Data will be collected by the primary investigator (PI) beginning immediately
after study enrollment. The baseline NIHSS will be performed by the treating
neurologists. The PI will perform all cognitive assessments as well as all follow up visit
activities. The PI has training and two years of experience in assessments for the study.
There are three measurement time points: baseline (within 72 hours after stroke),
Week 3 and Week 12 after stroke. The cognitive assessments take approximately 30
minutes to complete and the SDMT may be completed using either the written or the oral
test format. The Week 3-time point was selected because most acute inpatient
rehabilitation for patients with mild or moderate stroke has been completed and they will
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be transitioning home. Therefore, it will be of interest to evaluate changes between this
time-point and the Week 12 assessment. It is anticipated that by the Week 12 time point
the subject has resumed residence at home and is adjusting to new life conditions after
stroke. At Week 12 patients with stroke are entering the chronic stroke recovery phase
and assessment of their IPS compared to baseline should answer the hypothesis of IPS
impairment based on stroke severity.
At the baseline visit, standard of care information will be abstracted from the
medical records, including a pre & post stroke mRS and NIHSS performed by the
treatment team. The medical records will also be reviewed for demographic information
and evidence of rehabilitation therapies (PT/OT/ST).
At each of the three visits, the following assessments will be collected by the PI:
The Barthel Index (BI), NIHSS, the SDMT, the WAIS III Processing Speed Index (PSI):
Symbol Search and Digit Symbol – Coding, the CVLT-2II SF, Digit Span, and the
MoCA. The NIHSS indicates stroke severity and the SDMT and the PSI indicate IPS
impairment. The CVLT III and Digit Span will be used to indicate impairment of
working memory which can confound the IPS assessments, namely the Symbol Search
results. The MoCA assesses multiple cognitive domains including IPS and working
memory.
Quality of life (QOL) data will be collected by the PI at the Week 12 visit using
two QOL instruments, the Stroke Specific Quality of Life scale (SS-QOL) and the
Quality of Life in Neurological Disorders (Neuro-QOL). The QOL indicators will not be
collected at the Week 3 visit because the subject may still be undergoing rehabilitation or
just beginning adjustment to their new post stroke status. It is unlikely that the subject is
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fully cognizant of how much their lives have changed, holding out hope that they will
recover quickly. In the CASTLe study, the QOL results were not consistent between
these two measurements (Bursaw, submitted for publication). Additional research may
indicate a lack of sensitivity of the Neuro-QOL in mild stroke subjects.
Data Analysis Plan
Sample Size/Power Considerations
The power analysis for the sample size of n = 34 was completed using
GLIMMPSE, an online tool for calculating sample size and power in general linear
multivariate models (GLMM) (Kreidler et al., 2013; Muller & Glueck, 2012). With this
sample size, a repeated measures analysis with three time points will have 80% power to
detect as significant an effect size of f = .27, calculated by G3 power software (G*
Power, 2014). Effect size is based on Lunsford & Lunsford (1995) determination that a
medium effect size (epsilon = .50 or f2 of .15) implies that a trained observer may be able
to note an observable difference but testing is necessary to verify the differences. The
hypothesis is that, between the groups, the differences will be too small to be observed by
the average healthcare provider and testing is necessary. This is significant because it is
may indicate that patients with mild stroke experience an IPS impairment as severe as the
patients with moderate stroke but, historically, they do not receive similar levels of
medical and rehabilitation care.
Based on the selected effect size and an anticipated 20% lost to follow up, a
minimum of 33 subjects will need to be consented to obtain the necessary completed
follow up visits (N=30 subjects). Due to experiences with high lost to follow up reported
in other cognitive studies, it was decided that an additional 12 subjects will be enrolled to
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ensure adequate sample size at the end of the study. Therefore, a minimum of 46 subjects
will be enrolled in the study, with data analysis completed on at least 30 subjects.
The Digit Symbol-Coding (DSC) further characterizing IPS impairment, was
added after the fifth subject was enrolled. Because the intent of this descriptive study is to
more fully characterize IPS impairment after stroke, the PI continued to consider how
best to achieve that goal. Additional reading of stroke and non-stroke related material
produced information on the Processing Speed Index (PSI) being used in clinical settings.
The lack of baseline DSC will be considered during data analysis as it will effect four
subjects, with Subject 001 having expired prior to Week 3. Mixed-effects regression
models will be used for the study; a model tolerant of missing data, if it is missing
completely at random (MCAR). Data qualifies as MCAR when it is missing because of
either an instrument fails or is not completed, or when the probability of a subject
dropping out depends only on covariates included in the model (Gueorguieva & Krystal,
2004). Two reasons noted for missing data at this point in the study include DCS not
administered at baseline for four subjects and two subjects out of town for the Week 3
visit.
We have taken this approach of a small study because of the need to characterize
level of IPS impairment found in the acute population, the persistence of symptoms, and
any association of IPS impairment with stroke severity and decreased quality of life at
Week 12; this information is not available in the literature. The predictor variable is the
NIHSS score, with covariates of the SDMT, the PSI and the CVLT II. Possible
confounders are age and level of education. Additional sample description variables will
be BI, co-morbidities, race, and gender. A significance level of 0.05 will be used for all
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tests to assess statistical difference. The statistical analysis will be performed using
Statistical Analysis System (SAS, 2015) under the supervision of a biostatistician.
Analysis by Aim
Specific Aim 1: To determine the frequency and severity of IPS impairment, as
evidenced by abnormal SDMT values, in mild stroke (NIHSS < 5) compared to moderate
stroke (NIHSS >5) over time.
Descriptive statistics, including means with standard deviations, medians, or
proportions will be used to initially characterize the sample. Baseline differences between
those with mild and moderate stroke will be assessed using the t-test for independent
samples, chi-square tests, Fisher’s exact test, or Mann-Whitney U test, wherever
applicable.
Specific Aim 2: To evaluate the association between severity of IPS impairment
& QOL in mild stroke (NIHSS < 5) compared to moderate stroke (NIHSS >5) survivors
at 3 months.
A linear mixed model regression will be used to test for differences over time in
SDMT & PSI scores between those with mild and moderate stroke. The effects to be
tested will include group, time, time X group interaction and possible confounding terms
of age and education level. A multivariable linear regression will be performed to
determine association between stroke severity, SDMT & PSI scores and quality of life
scales at Week 12.
Specific Aim 3: To evaluate the correlation between IPS impairment and four
subsections of the Neuro-QOL compared to the overall Neuro-QOL score in mild
survivors of stroke at 3 months.
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A linear mixed model regression will be performed using two predictors, SDMT
& PSI scores, and four covariates, the Neuro-QOL subsections (Depression, Applied
Cognition-general concerns, Applied Cognition-Executive Function and Positive Affect
& Well-Being) to determine if there is a stronger association with these three than with
the overall Neuro-QOL score.
Potential limitations and solutions
The PI’s prior experience has indicated that there may be a larger than usual lost
to follow up percentage (>20%) in cognitive studies. Increase efforts to retain contact
with the subject and next of kin may assuage this concern. Effort to ensure compliance
will be attempted by periodic contact by phone and mail. The PI has worked as study
coordinator in other stroke studies and, in these prior studies, had an approximate 10%
lost to follow up rate.
Subjects may not be able to complete the baseline assessments within 72 hours of
stroke. If it is noted that a statistically significant amount of subjects are unable to
complete cognitive testing at baseline then the baseline time point will not be used in data
analysis, only the Week 3 and Week 12 time points. There is precedence for using a
Week 4 as baseline in other cognitive studies. Nevertheless, all subjects in the IPS pilot
study were enrolled and tested within 72 hours of stroke. In the CASTLe study, the study
team was able to enroll and complete cognitive testing with 44 out of 45 subjects within
24 hours of stroke (Bursaw, submitted for publication). This IPS study’s PI completed
75% of the CASTLe study enrollment and testing.
Additionally, performance of cognitive testing within 72 hours of stroke can
experience logistical and clinical challenges. One potential problem is the need to time
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the testing period to avoid conflict with the patient’s standard of care activities. Careful
coordination with the physician and nursing staff generates adequate study testing time.
The key to performing a successful cognitive study is frequent and open communication
between the study team and the subject, family members and the healthcare team.
Timetable
The study site admits approximately 60-80 patients with ischemic stroke in each month.
It is anticipated that it will take 8-12 months to complete the project (see Table 3).
Manuscripts from the dissertation will be submitted to peer-reviewed journals for
publication.
Table 3
Study activities time table from initial enrollment until planned publication submission
Table 1: Activity Month 1-3
Month 3-6
Month 6-12
timeline
Enrollment &
0- 39 subjects
Baseline testing enrolled, Week 3
visits ongoing
Week 3 and
Week 3 and Week
Week 12 testing
12 visits completed
Analysis/study
analysis completed
completion
and Dissertation
Phase
defended, manuscript
submission
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Abstract
Background Information processing speed (IPS) is an elemental cognitive function
impacting multiple - functions including memory, attention, and executive function, and - arithmetic, reading and writing academic skills. However, little research has been
conducted on IPS impairment in acute stroke. This article compares the frequency and
severity of IPS impairment in mild and moderate acute stroke and its impact on quality of
life.
Methods A longitudinal study of patients with mild stroke (NIHSS <5) and moderate
stroke (NIHSS 6-12) tested IPS and working memory on five cognitive measurements, at
three time points from 72 hours to 12 weeks after an acute ischemic stroke. A quality of
life (QOL) scale (Neuro-QOL) was administered to assess the relationship of QOL to
stroke severity and IPS impairment
Results Similar frequency and severity of IPS and memory impairments were noted,
regardless of stroke severity, in the sample of 30 patients (60% mild stroke). Statistically
significant improvement of IPS (p=.005) occurred with percentages of 100% impaired
(baseline), 97% (Week 3) and 79% (Week 12). Decreased quality of life associated with
IPS impairment was significant in the AC Executive QOL domain (p=0.04) but no
difference was noted based on stroke severity.
Conclusion There is evidence of minimal spontaneous IPS and memory recovery
regardless of stroke severity at 12 weeks post stroke. IPS was equally impaired in mild
and moderate stroke. Frequent and severe IPS impairment is clinically significantly
during the acute and rehabilitation phase of stroke recovery, potentially impacting a
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patient’s independence or ability to participate in his own care. The Neuro-QOL
measurement indicated impaired IPS impacts quality of life but only in relation to
executive function interference.
Introduction
A stroke occurs every 40 seconds in the US; that equates to almost 800,000
people experiencing a stroke annually (Mozaffarian et al., 2015). Currently,
approximately seven million adults are living with the consequences of stroke, with 30%
having been discharged from hospital to a skilled nursing home (Mozaffarian et al.,
2015). The annual financial impact on society totals $34 billion; projected to be $96
billion in 2030 (CDC, 2013).
An ischemic stroke is an infarction of brain tissue attributable to focal ischemia
resulting in permanent injury (Sacco et al., 2013), with severity indicated by scores on the
National Institute of Health Stroke Scale (NIHSS). The NIHSS score for mild stroke is
considered 0-4 (Fischer et al., 2010). In the literature, upper NIHSS range for mild stroke
varies from three to six (Hassan, Hassanzadeh, Tohidi, & Kirmani, 2010; Smith et al.,
2005) However, there may be minimal clinical differences in scores between 0-3, but
significant differences between 0-6 (Fischer et al., 2010). NIHSS range for moderate
stroke typically is 6-12; however, left hemisphere lesions can result in more profound
language involvement (Corballis, Badzakova‐Trajkov, & Häberling, 2012), confounding
cognitive assessment. Thus, upper range NIHSS for moderate stroke is 12, except in left
hemisphere lesions; then upper NIHSS should be 10 (S. Savitz MD, personal
communications, April, 2014).
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Regardless of stroke severity, at least 70% of survivors of stroke experience a
subtle cognitive dysfunction, information processing speed (IPS) impairment (Lesniak,
Bak, Czepiel, Seniow & Czlonkowska, 2008). Slowed IPS can persist up to five years in
mild to moderate stroke (Barker-Collo, 2012) and be unimproved by routine care
(Jokinen et al., 2015). Interaction between impaired IPS and attention can decrease
patient’s ability to understand or participate in healthcare (Lustig, Hasher & Tonev,
2006). Interaction between impaired IPS and memory can diminish the ability to perform
instrumental activities of daily living (IADL) (Winkens, 2006). IPS impairment is not
typically assessed in the acute stroke period regardless of stroke severity nor is it
typically assessed in mild stroke at any time period.
IPS is an elemental cognitive function, with a simple dimension (i.e. reaction
time) and a complex dimension; the complex dimension is known to impact multiple
other functions including memory, attention, reasoning, and executive function, and
academic skills such as arithmetic, reading and writing (DeLuca, 2008). The pervasive
nature of IPS impairment has been evaluated by extensive research in the areas of
education, aging and quality of life (Ball & Vance, 2008). Salthouse (1996) first defined
IPS as having two components known as Limited Time and Simultaneity mechanisms.
The consequence of faulty mechanisms is either 1) limited time is available to complete
the later steps of mental operations; available processing time having been consumed
performing the earlier steps or 2) information from the earlier mental processing is too
impoverished or degraded by the time other simultaneous information needs to be
processed (DeLuca, 2008).
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Almost immediately after a stroke brain plasticity aids the brain to adapt to
environmental pressures, experiences and challenges at many levels, through molecular
to cortical reorganization (Johansson, 2011). This active brain remodeling period lasts
approximately four to eight weeks after a stroke (Murphy & Corbett, 2009). Spontaneous
IPS recovery in humans occurs sooner in diffuse axonal injuries, such as mild traumatic
brain injury, then in focal brain injuries (Kinsella, 2008) such as stroke. To capture
variation over time due to neuroplastic changes, cognitive measurements need to be
repeated throughout this time window. Inpatient acute and rehabilitation care are usually
completed for patients with moderate strokes by three weeks after stroke, though the
brain is still undergoing neuroplastic changes. Twelve weeks after stroke is a typical
measurement time point in stroke research (Johansson, 2011) and can be viewed as a
demarcation between subacute and chronic stroke recover. Week 12 is outside the
window for neuroplastic changes (Murphy, & Corbett, 2009), however, cognitive
recovery may continue at a markedly slower rate for up to16-18 weeks (Christensen et
al., 2008; Suzuki et al., 2013).
Most survivors of mild stroke are discharged from the hospital with limited
rehabilitation, on the assumption there will be minimal residual effect (Edwards, Hahn,
Baum, & Dromerick, 2006). However, as many as 30% of survivors of mild stroke are
not discharged directly home and Romano et al. (2015) suspects this is due to cognitive
impairments. Cognitive impairment interferes with rehabilitation, nonetheless, specific
cognitive assessment and rehabilitation are neglected in early stroke (Johansson, 2011).
Limited research has been conducted on IPS impairment in acute stroke, due to concerns
that it does not represent a general cognitive profile (Lesniak et al, 2008). While this
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concern maybe accurate in relation to chronic cognitive impairment, it limits
identification and treatment of cognitive impairments in early stroke. In addition to the
NIHSS, clinical assessment of stroke patients focuses on level of disability. Global
disability scales, such as the Barthel Index (BI) and modified Rankin Scale (mRS), may
indicate minimal residual effect but not accurately measure cognitive impairment.
Furthermore, disability scales are not designed to measure the impact of cognitive
impairment on life activities and on QOL (Edwards et al., 2006). Use of a QOL scale,
responsive to cognitive impairments, may indicate that mild stroke is not as benign as
previously believed and it may indicate poor QOL can be associated with IPS impairment
rather than stroke severity.
The purpose of this longitudinal observational study was to describe the
frequency and severity of IPS impairment, in acute to subacute stroke, by stroke severity
and its relationship to QOL at 3 months. The primary hypothesis was patients, regardless
of stroke severity, will experience similar IPS impairment and QOL at three months after
stroke.
Method
This was a longitudinal observational study of 30 patients with acute ischemic
stroke divided into two groups by stroke severity. IPS impairment and QOL were
assessed in relationship to stroke severity, either mild or moderate stroke. A convenience
sample was enrolled at a large comprehensive stroke center hospital and cognitive testing
was completed at three time points: within 72 hours of stroke (baseline), post-stroke
Week 3 (+/- 5-days) and post-stroke Week 12 (+/- 14-days). All participants were
admitted under the care of a stroke neurology group and baseline cognitive assessments

IPS

50

were completed at the bedside by the investigator. Follow up visits were performed either
at a testing center, the participants’ home or work. Demographic information was
collected including age, gender, education level, medical history, MRI/CT findings, and
concurrent medications. A control group was deemed unnecessary due to the availability
of well-established, instrument-specific norm value tables used for diagnosis of cognitive
impairments. The investigator, a registered nurse, was trained to administer the tests and
research was performed as part of the author’s PhD dissertation program. The study was
performed with supervision of a neurologist and a neuropsychologist, was approved by a
university based institutional review board, and each participant signed an approved
written consent.
Sample size calculation was obtained using online G-Power program and verified
by a biostatistician during study design. The program determined significance can be
obtained with 90 data points or three data points for each of the 30 participants. The
statistical analysis for the study was performed by a biostatistician using SPSS (IBM
SPSS Statistics, Version 23) under the supervision of the investigator.
Subjects were included based on IPS impairment, as indicated by an abnormal
Symbol Digit Modalities Test (SDMT), stroke severity (NIHSS) at baseline, had
ischemic stroke identified by clinical exam, CT or MRI, and were between 18-80 years
old. Initial NIHSS inclusion criteria was based on stroke hemisphere (left: NIHSS less
than 11; right: less than 13). Participants were assigned to either mild (NIHSS 0-5) or
moderate groups (NIHSS 6-12) based on actual score; patients with mild dysarthria and
mild aphasia were also included.
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Patients were excluded if they had a severe prior neurological, psychiatric or
physical disorder which might confound testing (e.g. brain tumor, brain surgery,
traumatic or neurodegenerative brain disorders, dementia, schizophrenia, blind or mute,
etc.), or experienced prior cognitive impairment, drug or alcohol abuse, were unable to
stay awake for 30 minutes or unable to converse in English. Enrollment was age
restricted to less than 81 years old due to increased likelihood of cognitive effects of
normal brain aging.
The Informant Questionnaire on Cognitive Decline – Short Form (IQCODE), a
16-item questionnaire capable of indicating dementia in patients with stroke (Butt, 2015),
was used as a screening tool to assess prior cognitive impairment and was completed by a
proxy known to the patient for five years prior to enrollment. The IQCODE assesses
cognitive function through informant observations, related to life changes, rather than
direct assessment of a patient’s current cognitive status. The advantage of screening
observed behavior is that it is not dependent on culture, language or level of intelligence
(Jorm, 2004). IQCODE has a Cronbach’s alpha 0.97, a sensitivity of 73% for vascular
dementia, and has been previously shown to be useful as a screening tool for dementia in
patients with stroke (Butt, 2015; Jorm, 2004).
Five paper and pencil cognitive instruments were completed by participants, over
30 minutes at each visit, and were administered in a standardized sequential order (Table
1). A short rest break during testing was offered but declined by all participants. The
cognitive instruments (Table 1) measured IPS (SDMT, Digit Symbol-Coding (DSC), and
Symbol Search) and memory (California Verbal Learning test– 2nd Ed. Short form
(CVLT-II) and Digit Span). Research on IPS function and interactions, related to
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cognition, has produced term confusion in literature between IPS and working memory
(DeLuca, 2008). Therefore, a combination of IPS and working memory (WM)
instruments were included in this study. Working memory is a limited capacity system
that supports mental operations; a workspace for brief storage and manipulation of
information (Baddeley, Eysenck & Anderson,2009). IPS and working memory (WM) can
impact each other but not always consistently, as noted by DeLuca (2008) in the WM-PS
model. Therefore, association between these constructs was evaluated in the current
study.
The SDMT is considered a measurement least likely to suffer from construct
contamination by memory function interference (DeLuca, 2008) and was selected to
represent IPS impairment in this study. The other IPS tests combine to form the
Processing Speed Index (PSI) used in the Wechsler Adult Intelligence Scale III (WAIS
III), an instrument of frequently used in research and clinical settings (Strauss, Sherman
and Spreen, 2006). The PSI findings were evaluated to give indication of SDMT
measurement accuracy. Poor scores on both SDMT and PSI supported the determination
of IPS impairment in a participant. Strauss et al. (2006) identified adequate reliability and
validity (Table 1) and normative values for the IPS and memory instruments. To decrease
likelihood of practice effect, a 3-week interval (mean=23 days) was scheduled between
baseline and Week 3 visit. No significant practice effect at four-week testing intervals
have been noted in the SDMT (Smith, 2013) or the DSC, Symbol Search, and the Digit
Span (Strauss et al., 2006). The CVLT-II has a negligible practice effect at four-week
intervals (Woods, Delis, Scott, Kramer, & Holdnack, 2006).
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The Neuro-QOL, completed at Week12 visit, is a 13-section self-report domain
measurement for within-disease as well as cross-disease health-related quality of life
comparisons, used in neurology research and clinical practice (NINDS, 2010).
Traditionally, an investigator selects a few pertinent domains or short forms from the
static 13 domains form, based on an area of interest (Cella et al., 2012). Investigators
select domains of interest, related to physical, social, emotional or cognitive QOL, and
the selected short forms are completed by a participant. Likert scores (1-5) are tallied in
each short form with both positively-keyed and negatively-keyed items within the
instrument; limiting its ability to be used as a summarized measurement. Depending on
the polarity of the domain (negative or positive) the score may be high or low and may be
interpreted as much by extremity of polarity as by actual score (NINDS, 2010).
For this study, four domains were selected as the QOL domains most likely to be
affected by IPS impairment in patients with mild or moderate stroke. They included
Depression, Positive Affect & Well-Being (PAW), Applied Cognition General Concern
(AC General), and Applied Cognition Executive Function (AC Executive). PAW and
Depression were assessed because of potential impact of the psychological state on
cognition (Sheline et al., 2006). The four short forms were scored and interpreted based
on manual instructions (NINDS, 2010) and literature guidance (Salsman et al., 2013).
Neuro-QOL raw scores were converted to T-scores (mean 50, SD 10) (NINDS, 2010).
For this study, T score range of Fair (50 ≤ T-score < 60) was considered the median
scores, with all other categories either good or poor in increments of 10 points. Therefore,
Neuro-QOL scores were categorized as follows: Very good (T-score < 40), Good (40 ≤
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T-score < 50), Fair (50 ≤ T-score < 60), Poor (60 ≤ T-score < 70), Very poor (T-score ≥
70).
Patients with stroke are confronted with physical, cognitive, emotional, and social
changes (Nichols-Larsen, Clark, Zeringue, Greenspan, & Blanton, 2005). In preparation
for future research, the study explored an association between summary-scored NeuroQOL, stroke severity, and IPS impairment at Week 12. QOL is a multidimensional
construct and, at a minimum, several aspects of physical, emotional and social
functioning should be evaluated to fully understand QOL (Fayers & Machin, 2013). This
preliminary examination assessed any differences in a summarized overall score and the
scores from the four selected cognitive/affect domains, in relation to stroke severity and
IPS impairment. The exploration sought an alternate use for the form which may
encourage its creators in further instrument evaluation. The Neuro-QOL does not have a
uniform polarity. To calculate a summary score all items values needed to point in the
same direction, e.g. a more negative reply resulting in a higher score (WFU, 2015). After
all participants had completed the 13 Neuro-QOL short forms, the tabulated scores for
seven of the short forms were changed from positively-keyed to negatively-keyed
resulting in the direction of higher score equaling worse QOL. For example, response 1always became response 5- never. The reverse-keying was performed on tabulated scores
rather than by participants answering altered items. The reverse-keyed sections included
Ability to Participate in Social Roles and Activities, Satisfaction with Social Roles and
Activities, AC-General, AC-Executive, PAW, Upper Extremity Function -Fine Motor,
ADL and Lower Extremity Function -Mobility. The remaining sections without reverse-

IPS

55

keying were Anxiety, Depression, Fatigue, Emotional & Behavioral Dyscontrol, Sleep
Disturbance, and Stigma.
Statistical methods
Descriptive statistics (frequencies, mean, standard deviations) were used to
described the sample, IPS impairment, and quality of life (QOL). The NIHSS score was
selected as a predictor variable with the SDMT and Neuro-QOL scores as covariates to
characterize IPS impairment in participants with acute mild or moderate stroke
participants. Well-established normative value tables accounted for subject’s age and
education level thus eliminating the need to treat these concepts as potentially
confounding terms (Delis, Kaplan, & Ober, 2000; Smith, 2013; Wechsler, 1997).
Differences between mild & moderate stroke: t-test, Fisher’s exact test, or Spearman rho,
wherever applicable. A Spearman’s rho indicated significant correlation (p=0.001)
between SDMT and PSI scores for IPS impairment, therefore, to simplify analysis only
SDMT scores were used. A significance level of p < 0.05 indicated statistical difference.
A linear mixed model regression was used to test differences in SDMT, rate of
IPS impairment, and stroke severity over time. The effects tested included group, time,
and time X group interaction. The mixed-effects regression model is tolerant of randomly
missing data (Gueorguieva & Krystal, 2004). Differences in SDMT scores and NeuroQOL scores, based on stroke severity or IPS impairment, were assessed using linear
mixed model regression: using SDMT as a predictor to determine if there is an
association with an overall Neuro-QOL score.
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Results
Sample Description
This was a longitudinal observational study of 30 patients with acute ischemic
stroke divided into two groups. Categorized by NIHSS score at baseline, 60% of
participants had a mild stroke (n=18) and the remaining had a moderate stroke (n=12).
Participants age range was between 45-79 years. Patients admitted to the hospital’s stroke
neurology service were screened (N=1194) from 10/8/2014 until enrollment was
completed on 9/15/15. Analysis was based on participants who completed the Week 3
visit. Demographic characteristics, NIHSS findings, Barthel Index (BI) and modified
Rankin Scores (mRS) are presented in Table 2. Four risk factors for mild cognitive
impairment (Gorelick et al., 2011) were present in sample: hypertension (n=25), cardiac
disease (n=13), diabetes (n=11), and hyperlipidemia (n-9). Fisher’s Exact test showed no
significant difference related to these risk factors between those with mild versus
moderate stroke. One participant (baseline NIHSS=1) had a second stroke prior to Week
12 visit. No difference was found on t-test using SDMT scores between this participant
and other participants with mild stroke, at baseline or Week 3. Therefore, he remained in
the study. There was no difference in age or education between mild and moderate stroke
participants (Table 2). Random missing data included DCS not administered in four
participants at baseline and no data collected for the participant with a second stroke at
Week 12.
The IQCODE questionnaire was used to exclude one patient for prior cognitive
impairments; information which had not been noted in medical history or at initial family
interview. Four patients with prior mild stroke were enrolled: three of the patients, aged
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52-56 years, were actively employed and one, aged 73 years, was retired but active. Their
IQCODE evaluations identified no prior cognitive impairments.
Exclusions
Of the 42 participants enrolled in the study, 12 did not complete the study (28%)
and were excluded from analysis. One died; one moved due to persistent unemployment;
five withdrew consent; five (13%) were lost to follow up after baseline testing.
Participants with mild stroke accounted for 60% of withdrawn or lost to follow up. The
participant who died and the one who moved had mild strokes. Reasons to withdrawal
given as: lack of interest in research (n=3) and inconvenience of research (n=2). No
difference was found on t-test between enrolled participants and non-completing
participants for gender, NIHSS, education or all cognitive tests scores. There was a
statistical, but not clinical, age difference between group means (t (37) =1.443, p<.05),
with non-completing participants being younger than participants (mean=57, SD = 15
versus mean= 63, SD =9).
Five exclusion criteria (Table 3) accounted for the majority of screened patients
(77%) being excluded: including hemorrhagic stroke, NIHSS criteria, age greater than 80,
no stroke, and stroke onset greater than 72 hours prior to admission. Three patients with
mild stroke were excluded due to normal SDMT scores at baseline; thus, of the patients
with mild stroke who were tested (n=26), 12% did not have IPS impairment. There was
no significant difference in their NIHSS means compared to means of enrolled
participants with mild stroke.
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IPS Impairment and stroke severity
Overall sample’s SDMT score frequency was abnormal for 100%, 97% and 79%
of the participants, respectively at baseline, visit 2 and visit 3. Linear mixed modeling
indicated IPS impairment change, either in frequency or severity, was not dependent on
stroke severity; IPS impairment did improve over time (p=0.005), with similar
improvement over time regardless of stroke severity; from 100% to 77% for mild stroke
participants and to 83% for moderate stroke participants at Week 12 (Figure 1). Linear
mixed modeling for the combined sample demonstrated IPS impairment severity also
decreased by Week 12 regardless of stroke severity; participant SDMT mean points were
23, 28, and 33, respective of the three visit time points. Normal SDMT score range is 5162. Effect size could not be calculated due to no difference in IPS impairment between
mild and moderate stroke groups at any time point.
Of note, for the three visits, all CVLT-II scores were abnormal in 100% of
participants, while Digit Span scores were abnormal for 83%, 70% and 66% of
participants, respectively. However, there was no correlation between the SDMT scores
and the two memory measurement scores at any of the three time points.
IPS Impairment and Quality of Life
At Week 12 there is evidence of minimal disability in the sample: modified
Rankin scale (mRS) (mean 2, SD 1) and Barthel Index (BI) (mean 92, SD 20), and
NIHSS (mean 1, SD 2). Independent sample t-tests indicated no difference in QOL by
stroke severity at Week 12, i.e. QOL was similar in both mild and moderate stroke
participants. Most participants characterized their QOL as fair (28%) to good (48%) with
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20% as poor or very poor. Of note, there was no significant association between SDMT
scores and the Depression short form QOL (p=0.52). Decreased quality of life was
associated with presence of IPS impairment at Week 12, though significant only in AC
Executive QOL (p=0.04). Better AC Executive QOL scores correlated with non-IPS
impaired participants (mean 11.3, SD 2.7) rather than impaired participants (mean 16.1,
SD 9.2) (Table 4). Finally, although not a significant difference, a similar trend was noted
with better QOL scores in non-IPS impaired participants for Depression, AC-General and
PAW: 11.3(5.0), 15.7(7.0), 14.2(8.5) than in IPS impaired participants: 13.4(8.8),
20.7(10.1), 17.9(10.4), respectively.
Exploratory analysis
As the Neuro-QOL total score has not yet been validated, its use and analysis in
the current study were exploratory (Table 4). Participant totals by categories, from very
good to very poor, were n=3, n=12, n=7, n=1, n=3, respectively. A Spearman’s rho
indicated a correlation between Neuro-QOL summary score and SDMT scores (p=0.03).
Higher SDMT scores were associated with better QOL. However, independent sample ttests did not indicate a difference in Neuro-QOL summary scores between participants
categorized as IPS impaired or unimpaired (i.e. abnormal or normal SDMT scores,
respectively). An association among stroke severity, summary Neuro-QOL score and its
four pre-selected domain or short form scores was not statistically evaluated due to the
small sample size. However, over 70% of participants with mild stroke self-reported a
good or very good summarized QOL with 18% of mild stroke participants and 16% of
moderate stroke participants reported poor or very poor on the summarized Neuro-QOL.
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Discussion
This study of 30 participants with acute ischemic stroke and IPS impairment
presents three key findings. First, all participants experienced persistent impairment in
IPS and working memory during the first 12 weeks, regardless of stroke severity. This is
not unexpected with brain injury, however, there is limited studies exploring this during
acute stroke, and in particularly those with mild stroke, with one previous study
reporting……previously patients with mild stroke were assumed to have minor deficits
which recover spontaneously (Edwards et al., 2006). In the current study, frequency of
IPS impairment was100% with a 21% reduction in 12 weeks. In an acute stroke study
which included both mild and moderate??, Hurford, Charidimou, Fox, Cipolotti, &
Werring (2013) linked speed and attention as one domain, indicated it was the most
frequently impaired and had the most rapid recovery; 72% of patients were impaired with
a 50% recovery rate at three months. However, the sample was not separated by stroke
severity and two separate cognitive functions were measured together. While evaluating
improvement over time, Barker-Collo et al. (2012) and Cumming, Marshall & Lazar,
(2013) determined executive function and IPS remained the most impaired functions five
years after stroke. Rasquin et al. (2004) noted mental speed improved after one-year but
continued to have more impact on cognitive functioning than memory impairment.
The results of this study support that persistent and pervasive IPS impairment
must be considered when interacting with patients with stroke, regardless of stroke
severity during the acute stroke period. Patients with stroke have difficulty either
comprehending or framing questions to ask, resulting in anxiety and feelings of
inadequacy (Olofsson, Andersson, & Carlberg, 2005). IPS impairment related to
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dysfunction in limited time and/or simultaneity mechanisms are likely a component of
these difficulties. Patients with stroke may require more time to process information or
may need information presented in smaller amounts for effective processing. Instead,
they receive care in loud and frequently frenetic environments where they are expected to
give consent before they can gain access to time sensitive stroke treatment. During the
acute stay patients receive incalculable instructions, from initial encounter to discharge
instructions, regardless of limited ability to understand. Additionally, Suzuki et al.,
(2013) suggests patients can be identified as non-compliant without providers
determining if the patient actually understands the directions (Suzuki et al., 2013).
As noted earlier, in this study IPS impairment percentages at Week 12 (79%)
exceeds similar findings noted in other studies. One explanation may be construct
interference. Other studies have linked IPS and either attention or memory in a
measurement. There is a conceptual relationship between abnormal IPS and memory,
nevertheless, IPS can be impaired yet have little impact on memory and vice versa
(DeLuca, 2008). The measurements in this study were specifically selected to limit
construct interference (Strauss et al., 2006). However, in the current study there was no
significant correlation between the SDMT and the two memory measurements (CVLT II
and Digit Span) at any of the three time points.
The second key finding is the acknowledgement that other possible causes of poor

QOL, such as disability and depression, must be evaluated in order to isolate the impact
of cognitive impairment on QOL. Depression has been reported previously as being
associated with poor QOL after stroke (Haacke et al., 2006). However, in this study, the
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results for the Depression short form did not reach significance, indicating no relationship
between depression and poor AC Executive QOL.
Healthcare providers in research and clinical care assess impairment after stroke
using a variety of tools. Measurements in common use in the clinical setting, such as
NIHSS, mRS, BI, and Neuro-QOL are not designed to adequately measure all aspects of
stroke injury and recovery (Kasner, 2006), particularly cognitive impairment (Sangha et
al., 2015). In this study, the NIHSS, mRS, and BI indicated minimal disability and only
one QOL short form was significant at Week 12. Despite this data, the SDMT test
indicated 79% of participants had IPS impairment. One reason could be IPS impairment
does not impact QOL or instrumental ADLs, however, this is not supported in literature
(Barker-Collo, 2006; Cumming, Brodtmann, Darby, & Bernhardt, 2014). A second
reason is the NIHSS, mRS, and BI scales give more weight to physical impairment than
cognitive impairment, thus producing a biased view of patient condition (Gottesman et
al., 2009; Kasner, 2006). Up to 60% of patients defined as nondependent on these scales
have been previous reported to have some degree of cognitive impairment (Pendlebury,
Rothwell, Mariz, Mehta, & Baig, 2010).
The third key finding is Neuro-QOL does not adequately screen for certain
cognitive impairments, like IPS impairment. Indeed, 18% of participants with mild stroke
and IPS impairment in this study indicated poor QOL. These findings contradict another
study (Sangha et al., 2015) of patients with mild stroke using Neuro-QOL to assess QOL.
General cognitive impairment was associated with poor QOL in only 8-16% of
participants with mild stroke and transient ischemic attack (TIA) (Sangha et al., 2015).
One difference is in the previous reported study in the literature, the sample included
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patients with TIA, which may present with a different cognitive profile compared to mild
stroke.
Neuro-QOL was designed as an efficient, flexible and precise measurement of
the physical, emotional, cognitive and social patient functions (Gershon et al., 2012). The
cognitive sections were developed and validated as a measurement with a common
language for use in multiple neurological populations (Gershon et al., 2012). However, a
general instrument may not have the depth required to identify such a subtle dysfunction
as IPS impairment (Ready & Ott, 2003). Careful consideration should be given to use of
QOL instruments in stroke research or the clinical setting. Unless specifically designed to
indicate how cognitive status impacts QOL, these instruments may not adequately assess
patients with stroke. QOL measurements have three potential drawbacks: they may not
be sufficiently relevant or sensitive to measure a particular population (Fayers & Machin,
2013) they must be self-reports and yet may be difficult to complete for elderly patients
(Carlson et al., 2011) or those with IPS impairment.
Neuro-QOL, while one of the better self-report QOL instruments (NINDS, 2010),
may be limited in measuring changes in QOL impacted by IPS impairment. In elderly
patients with stroke many life activities with aspects of time pressures, like managing
finances and appointments, have been assumed by spouses or adult children. Thus,
patients may be guessing on 60% of the activities assessed by the AC-Executive; the one
Neuro-QOL section indicated as statistically significant in the study. AC-General appears
to focuses on memory and attention, with only one item addressing IPS. AC-Executive
does not directly address IPS, nonetheless, it does present items impacted by time
pressures. Time pressures can exacerbate faulty limited time and simultaneity
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mechanisms, resulting in slow IPS (Salthouse, 1996). Additionally, there is concern with
the reverse scoring on the Neuro-QOL Likert scale which occurs between and within
domains. Reverse scoring relates to items in which the score indicates the opposite of the
construct being assessed. For instance, in the Anxiety domain “1-Never” is a positive
response, however, in AC General it is a negative response. Within the Satisfaction with
Social Roles section “1-Not at all” response may be positive or negative, depending on
the item presented. Reverse scored items are especially problematic for older participants
(Carlson et al., 2011) and very likely for persons with IPS impairment, due to the need for

complex reading comprehension (DeLuca, 2008).
Several limitations do exist in the current study. The a priori effect size was not
calculated due to no statistically significant difference in SDMT scores by stroke
severity. While this supports the hypothesis of no difference between the mild and
moderate groups, there is concern that the sample was too small to identify a very small
difference. In addition, the sample size limited analysis of the totaled Neuro-QOL score
based on stroke severity or IPS impairment. However, the exploratory nature of this
inquiry has laid the foundation for further research. Another limitation, in study
reproducibility, relates to completion of follow up visits. The study was based at a
metropolitan hospital using a rescue helicopter to transport patients hundreds of miles to
receive stroke treatment. Therefore, to complete follow up visits some participants had to
travel significant distances to a testing center. To decrease lost to follow up the
investigator met participants at locations convenient to the participant. This required
significant travel time for the investigator, averaging 85 minutes per visit, but did equate
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to a relatively low lost to follow up percentage (13%). To perform a similar study an
additional exclusion of distance to testing center may need to be imposed.
Conclusion
Findings from the current study have profound implications in clinical care and in
research for patients with stroke. Consideration should be given for adopting the use of
the SDMT in clinical settings. The SDMT, as a screening instrument, is brief, easily
scored at the bedside, requires only a few minutes to administer, and uses either written
or oral format (Sheridan et al., 2006). For patients with low NIHSS this may provide the
physician with sufficient information regarding the need for emergency treatment.
Further, precautions should be taken to avoid rushed explanations of care at the bedside
or research consent forms of extended length and complexity. Patients with IPS
impairment have slow thinking to a degree not previously appreciated, impacting their
ability to understand and actively participate in their own care. Awareness of IPS
impairment can assist nurses in formulating effective patient education and therapists in
shaping rehabilitation goals and capabilities.
This study provides evidence of minimal spontaneous IPS and memory recovery
in patients with mild and moderate stroke after 12 weeks. Cognitive impairment is not
minor in patients with mild stroke; IPS impairment often becomes chronic. Therefore,
neurocognitive assessment and initiation of treatment should be considered in the acute
setting, while the brain is undergoing its most active neuroplastic changes. Future
research should be done on the factors that promote or hinder cognitive recovery within
the first 12 weeks. Additionally, research on QOL instruments is necessary, to
investigate what actually causes poor QOL in patients with mild stroke. Discussion with
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the Neuro-QOL creators may encourage further analysis of the scale in the stroke
population or, possibly, addition of a domain specifically evaluating IPS. As a small
observation study the information obtained was sufficient to encourage design of a larger
randomized trial regarding instrument development, to further identify interactions
between IPS and other cognitive functions.
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Abstract
Purpose/Objectives: To provide a clearly constructed definition of Patient-centered
Cognitive Recovery in patients with Stroke (PCRS)
Data Sources: Peer reviewed articles and book chapters.
Data Synthesis: Cognitive impairment affects patients with stroke and can lead to
dementia. Recovery is unpredictable, prolonged, and is patient centered and patient
controlled. Multiple models of cognitive recovery exist but are limited or discipline
biased. These models are hampered by the user’s viewpoint or aims, use of loose or
confusing terms, and the restrictiveness of the biomedical model.

However, a

collaborative patient-centered cognitive recovery model has not been previously
explored.
Conclusions: PCRS is a transitional state in which a person’s cognitive capacities can be
modified to approach or achieve pre-injury levels. Cognitive changes are promoted or
hindered by the interaction between personal capacities and a person’s resources.
Antecedents to the transitional state are stroke with cognitive impairment, some level of
self-awareness, and absence of significant pre-existing cognitive disorder. Consequences
include improved cognitive function and quality of life; and ability to function in the
community.
Implications for Nursing: Cognitive recovery is not a one size fits all process. The PCRS
model promotes collaboration, self-care, and provides a framework to guide all
healthcare providers in identifying and addressing patient needs beginning in the acute
care setting.
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Introduction
Stroke can impair the individual mental attributes which allow a person to
understand the world and to function within it. Mental abilities and processes are the
cognitive capacities required for thinking and knowing. Cognitive impairments are
experienced by 50-90% of survivors after stroke (Gottesman & Hillis, 2010).
Approximately 17 different cognitive impairments can occur after stroke and, further,
impairments can have a multiplicative impact (Donovan et al., 2008). The lateralized
nature of cognitive impairments, along with the physical and emotional impact of stroke,
requires treatment to be planned, organized, and comprehensive. Cognitive impairment
and, therefore, cognitive recovery concerns several different health disciplines. Each
discipline considers the recovery concept from the bias of their own medical,
psychological or rehabilitation prospective (Davidson, Lawless, & Leary, 2005). This
paper will present a concept synthesis for cognitive recovery and will display different
aspects of patient-centered cognitive recovery for stroke patients within a
multicomponent model.
The concept of health recovery is critical in health care but is difficult to define or
even to identify precisely (Collier, 2010). Recovery is a transitional state from illness to
wellness (Skärsäter & Willman, 2006). The understanding or interpretation of recovery
depends on which discipline is viewing the illness or injury and even upon whose
prospective: patient or healthcare provider. Multiple models of cognitive recovery exist
but controversy remains on their adequacy, both within and without the particular
discipline (Collier, 2010; Whitley & Drake, 2010; Wilson, 1998). Some rehabilitation
and psychiatric models have begun to reach beyond traditional biomedical model format
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by adding psychosocial dimensions (Albert & Kesselring, 2012; Wilson, 2002b).
However, it remains remain essentially biomedical models with the goal of diagnosing
and treating, i.e. the concept generally expressing or guiding provider activities. Patient
centered care involves a collaboration between provider and patient (Stewart et al., 2000).
Understanding how and why cognitive recovery is happening requires looking at how
bio-psychosocial domains are interacting within the person and what may influence these
interactions.
The complex nature of cognitive recovery in stroke requires a top down
knowledge synthesis approach to more fully explore the changing state. A concept
synthesis is a new way of grouping or ordering information when relevant information
such as attributes are unclear or unknown (Walker & Avant, 2005). The synthesis will
add new insights and may point to a foundational basis or connection between the various
recovery models and suggest more comprehensive interventions.
The current concept synthesis examined sets of related concepts and is supported
by aspects of two parent theories: Neuman System theory (Neuman & Fawcett, 2001) and
Orem’s Self-care theory (Orem, 2001), specifically, the System Model’s environment
constructs and the concepts of self-care and of self-care agency. This concept synthesis
represents a clear definition of patient-centered cognitive recovery as it pertains to
patients with stroke, identifiable antecedents, attributes and consequences of the concept,
and a model case and related cases.
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Literature Review
The study of cognition and cognitive recovery have been of scientific interest
since 400 B.C.E. when Plato first determined the brain was the seat of all mental
processes (Crivellato, 2006). Cognition is defined as the set of all mental abilities and
processes related to knowing, specifically capacities for attending, remembering and
reasoning, and activities such as problem solving, decision making, comprehension,
language use, etc. (APA, 2015). Thus in stroke, cognitive impairment is an intrinsic
deficit that alters these functions and capabilities. Jaillard et al. (2009) noted 92% of
patients were impaired two weeks after stroke and between 38-92% are impaired at 12
weeks, depending on clinical factors (Brainin et al., 2015; Patel, Coshall, Rudd, & Wolfe,
2002). Spontaneous cognitive recovery by 12 weeks may account for some degree of
improvement (Cramer, 2008). However, cognitive impairments have been noted in at
least 80% patients with stroke for two years, with a 10-fold increase in dementia rates in
this population (Rasquin, Lodder, & Verhey, 2005). Within five years of stroke, 30-50%
patients with cognitive impairment advance to dementia (Alvarez-Sabin & Román, 2011;
Leys, Hénon, Mackowiak-Cordoliani, & Pasquier, 2005) with a 3-fold increased risk of
death (Desmond, Moroney, Sano, & Stern, 2002). Therefore, interventions to promote
recovery continue to be of interest.
The terms cognitive rehabilitation and cognitive recovery are used
interchangeably but are not well defined in literature (Bour et al., 2010; Das Nair &
Lincoln, 2008; Green et al., 2008). Rehabilitation is defined as physical restoration by
therapeutic measures and reeducation, from the 16th century Latin word habilitate
meaning to make fit or capable (Merriam-Webster’s Collegiate Dictionary, 2015). The
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American Congress of Rehabilitation Medicine (SCR, 2015) defines cognitive
rehabilitation as a service intent on establishing new patterns of cognitive activity or
compensatory mechanisms or reinforcing, strengthening, or reestablishing previously
learned patterns of behavior.
Recovery, a more inclusive term from the 15th century, refers to changes in a state
of being, as in regaining or returning toward a normal or healthy state (MerriamWebster’s Collegiate Dictionary, 2015). The term encompasses the more holistic change
in mode or condition of being rather than a response to treatment. In the self-care theory,
changes in state require the human being to attend to and deal with impairments
themselves (Denyes, Orem, & Bekel, 2001). Considering recovery as a state extends the
concept of healing beyond biomedical models of rehabilitation. While cognitive recovery
is not well defined, some recovery outcomes have been identified. A meta-analysis of
cognitive rehabilitation research by Cicerone et al. (2011) reported multiple descriptive
indicators of cognitive recovery including compensation without necessarily improving,
improvement of overall cognitive function or of underlying neurocognitive system,
effectiveness of interventions and cognitive remediation.
In addition to outcomes, certain antecedents have been identified, namely
neuroplastic changes in the brain. Murphy and Corbett (2009) view cognitive recovery as
varying degrees of behavioral compensation and spontaneous return of function or
improved performance provided by the remaining and newly developed brain circuits.
This implies that recovery is not dependent on rehabilitation, though logically recovery
benefits from it. Physical rehabilitation takes advantage of brain neuroplasticity by
beginning almost immediately after stroke (Duncan et al., 2005). This immediacy
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addresses caveats to Murphy and Corbett (2009) view of cognitive recovery after stroke.
Neuroplasticity is dependent on a critical time window opening shortly after injury, there
is sufficient undamaged brain, and training-dependent effects. There are synaptic-based
learning rules which require adequate synaptic input (stimuli) and early mechanisms to
redistribute synaptic strength (neuroplasticity). However, cognitive rehabilitation
research is typically performed months or years after brain injury (Beasley & Davies,
2013; Dawson et al., 2013; Kerhoff et al., 2014); an exception is aphasia research which
frequently begins 2- 4 weeks after stroke (Bakheit et al., 2007; Conklyn et al., 2012).
Formal cognitive rehabilitation is typically dependent on physician referral 1-3 months
after the hospital discharge.
Attempts to create a theoretical model expressing cognitive recovery or
rehabilitation are hindered by three factors. First, there is a general lack of unity or
agreement over key terms related to cognitive operations such as what constitutes
impairment (Jokinen et al., 2006; Nys et al., 2007), impact of impairment (Edwards,
Hahn, Baum & Dromerick, 2006; van Schouwen-van Kranen, 2014), treatment factors
(Särkämö et al., 2008; Hachinski et al., 2006), how to measure recovery (Bour et al.,
2010; Castellanos et al., 2010; Liman et al., 2011), or what other factors may impact
recovery (Carlsson, Moller & Blomstrand, 2009; Greenop, Almeida, Hankey, van
Bockxmeer, & Lautenschlager, 2009; Mayo, Fellows, Scott, Cameron & WoodDauphinee, 2009). Second, term imprecision in literature, i.e. the interchangeability of
cognitive recovery and rehabilitation, support concerns that neuroscientists use terms in
conflicting ways that vary from their original meanings (Figdor, 2012). This term
looseness promotes a systematic lack of relationship between the original meanings of
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mental terms and research findings, thus confusing research implications and the nature
of cognitive operations.
The third factor hindering successful cognitive recovery model creation relate to
model structure. Structurally, attempts to model cognitive recovery have depended on a
biomedical model (Albert & Kesselring, 2012; Wilson, 2002b). The earliest treatise on
cognitive rehabilitation, in the 1600s, discussed treatments for brain injury related
impairments (Boake, 2003). Biomedical models focus on natural sciences and consist of
practical applications of these sciences to illness and rehabilitation (Goldenberg, 2006).
Natural science lacks the scientific nomenclature for the human experience crucial to the
experience of illness and recovery. As a result, illness and recovery becomes a
breakdown or repair of objectified body-machine (Goldenberg, 2006). Of course, people
are more than just physical entities or disease exemplars and the goal of recovery is as
much reintegration of the person as it is physical restoration.
To date, cognitive rehabilitation is considered a modality based process whereby
health service professionals ameliorate or alleviate cognitive impairment (Wilson,
2002a). The model does not adequately incorporate psycho-social aspects of recovery or
the mediators and moderators of health; the primary focus is not on the individual patient,
who will ultimately control the progress of treatment. Cognitive recovery is the process
whereby a patient’s cognitive capacities are regained and reach baseline performance
(Linqvist, Schening, Granstrom, Bjorne, & Jakobsson, 2014); the patient is the actor and
interventions are the tools.
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In summary, the literature review demonstrates a lack of unity in term use or to
demonstrate a comprehensive recovery model, despite multiple attempts ongoing for
almost two decades. Cognitive rehabilitation models have taken into account physical
impairment, treatment modalities and, to a degree, the psychosocial aspects of stroke
treatment. However, the models fail to center recovery around the patient, who is most
impacted by, and most significantly impacts, recovery progress. This paper will explore
the concept of patient-centered cognitive recovery in stroke.
Patient-centered Cognitive Recovery in Stroke
The term recovery has been used several in diverse health disciplines, i.e. in
rehabilitation, physical and mental health. In mental health, recovery is a therapiesinduced reduction or control of symptoms and a return to baseline levels of functioning
(Whitley & Drake, 2010). Though it is the consumer of the mental health services who
identifies recovery, i.e. symptoms no longer overwhelm and incapacitate. Wilson (2002b)
created one of the most comprehensive biomedical models, the provisional model of
cognitive rehabilitation. However, she recognized the impossibility of addressing all the
complex problems of patients with cognitive impairment using the medical model.
Biomedical models are excellent at finding solutions to specific problems and measuring
response to interventions. But patients with stroke are more than their problems.
Therefore, a more fluid model is needed, one which focuses on the main actor in the
recovery process.
For the purpose of the current concept synthesis the model, patient-centered
cognitive recovery in patients with stroke (PCRS), is defined as a transitional state in
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which a person’s cognitive capacities can be modified by personal capabilities and
environments to approach or achieve the person’s pre-injury level of cognitive health
(Figure 1).
Transitional state, a fundamental concept in nursing theory, occurs between two
fairly stable states pertaining to illness and health (Chick & Meleis, 1986). Stable state
refers to a relatively unchanging condition, not to medical stability. An acute stroke will
not become an un-stroke and, therefore, will be followed by a transitional state which
results in an outcome of cognitive improvement or subpar recovery. The PCRS model is
applicable in stroke specifically because stroke follows an established injury and
recovery pattern. Additionally, neuroplastic changes after stroke are the result of
behavioral, sensory, and cognitive experiences (Kleim & Jones, 2008); if experiences are
therapeutic or positive then the outcome is cognitive improvement. In PCRS model,
transitional experiences are driven by patient needs and are supported by two cognitive
treatment approaches: relearning and compensatory strategies (Miller et al., 2010).
The main component of the model is named cognitive accommodation (Figure 1)
and is considered the workstation for the translational state. Accommodation, a Latin
word circa 1600, is a state or process of adjustment or adaptation, as of differences or to
new circumstances (Dictionary.com, 2015). Accommodation in learning theory is a
radical conceptual change occurring when central concepts are replaced or reorganized
(Posner, Strike, Hewson, & Gertzog, 1982). In cognitive accommodation, a patient’s
cognitive capacities change in response to interactions between his personal capabilities
and his environments. Personal capabilities (acceptance, agency and congruence) are
internally oriented activities directed to the control of behavior that people need to
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perform self-care (Orem, 2001). The environments (Figure 1) are a person’s resources or
interactive forces which bind together to aid or hinder recovery (Neuman & Fawcett,
2001). The outcome of cognitive accommodation depends on the interactions that
occurred in the workstation. If they are supportive and adequate than recovery will occur.
If not, there will be no significant improvement of the cognitive impairments.
Defining attributes
Defining attributes are the cluster of characteristics most frequently associated
with the concept and allow the broadest possible insight into a concept (Walker & Avant,
2005). Several disciplines use the cognitive recovery concept but each lack some aspect
or key attribute. The closest recovery concept is seen in the mental health discipline but it
does not account for the physical environment. Thus, key attributes for the current
concept will include a synthesis of attributes from the other disciplines and the parent
theories. In the PCRS model attributes are divided into environments, acting as the
framework in which a person functions, and personal capabilities which are proactive
abilities acting as drivers and guiders of behavior. These attributes are modified in some
degree, either positively or negatively, during the translational state. The work of
cognitive accommodation involves the supportive or deleterious interactions within and
between the attributes. The interactions must be more supportive than deleterious for
effective recovery and to produce self-care promoting decisions and actions.
Environments
The four environments (physical, internal, created and external) are forces or
interactive influences within or without the patient, unique to each person based on past
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life experiences and current physical or social conditions (Orem, 2001). In the PCRS
model there are no dividing lines between the environments, indicating each one is able
to impact the other three.
The physical environment is any purely physical human factor in stroke and
health, including brain neuroplasticity (Murphy & Corbett, 2009), age (Green et al.,
2008), co-morbidities (Kruyt et al., 2008; Patel, Coshall, Rudd, & Wolfe, 2003),
decreased level of consciousness after stroke (León-Carrión et al., 2012), biological
changes due to disrupted sleep state (Goel, Rao, Durmer & Dinges, 2009) and severity of
physical impairments, size and location of lesion (Sachdev et al., 2006). Lesion location
can sometimes indicate which cognitive functions will be most affected and, logically,
larger lesions have higher neuroplastic repair requirements, and thus slow cognitive
recovery. Also known to slow recovery, fragmented sleep induces a fatigue effect when
cognitive tasks are extended or demanding (Goel et al., 2009). Overall the physical
environment, not included in the Neuman system model, plays a significant role in
cognitive recovery after stroke.
The internal environment is defined as all internal forces or interactive influences
contained solely within the boundaries of the patient (Neuman & Fawcett, 2001). In
stroke, they can include depression (Narushima, Chan, Kosier & Robinson, 2014), apathy
(Mayo et al., 2009), anxiety, fear, delirium (Rijsbergen et al., 2011), personality (Carver
& Connor-Smith, 2010), cognitive reserve (Sharp, Turkheimer, Bose, Scott &
Wise,2010), pre-stroke dementia or other psychiatric history. These are psychiatric
factors that influence learning, perception and behavior.
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The created environment is representative of an open system exchanging energy
with the other environments (Neuman & Fawcett, 2001); similar to personal capabilities,
this environment acts as background guiders of behavior. In the Neuman System model
this environment is inherently purposeful and functions as a protective perceptive coping
shield, unconsciously developed with a main goal of stimulating system health. In
patients with stroke, the created environment includes belief systems, perceptions of life
(McKenna, Liddle, Brown, Lee, & Gustafsson, 2009), self- esteem, attitude, self-efficacy
(Aben, Busschbach, Ponds, & Ribbers, 2008), learned helplessness (Mayo et al., 2009),
resilience, cognitive reserve (Stern, 2009), and reactions to uncertainty. Recovery is
enhanced by attitude and self-efficacy, for instance, motivating patients to exceed health
provider expectations (Medin, Barajas, & Ekberg, 2006) while defeatist beliefs can slow
progress.
The external environment is defined as forces or interactive influences external to
the patient (Neuman & Fawcett, 2001). They can include social support (Glymour,
Weuve, Fay, Glass & Berkmanb, 2008), access to care, social interactions (Mukherjee,
Levin, & Heller, 2006) and resources (Chumbler et al., 2004), cost (healthcare cost,
financial loss, etc.) and holistic therapy (Cicerone et al., 2011). The forces of the external
environment are contacts or conditions outside the patient which hinders or helps
recovery. A simple combination of physical therapy and occupational therapy does not
meet the needs of stroke patients (Cicerone et al., 2011; Nys et al., 2005).
Therapy is a mediator variable between cognitive accommodation and positive
recovery indicators. A mediator variable explains the relationship between the two other
variables (Baron & Kenny, 1986). In the PCRS model, holistic therapies are specifically
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identified because these therapies address the multiple needs of the patient with stroke.
Due to the brain’s limited neuroplasticity window after stroke and the need for high
levels of stimulating input (Murphy & Corbett, 2009), effective recovery is dependent on
comprehensive-holistic neuropsychological rehabilitation (Cicerone et al., 2011).
Therapies can be cognitive, physical, behavioral, social or psychiatric in nature (AlvarezJimenez et al., 2013; Cicerone et al., 2011) and are initiated and conducted by trained
providers.
The final pathway or visible expression of the accommodation workshop is
through the external environment. In other words, the mediator explains how the external
events (participation and response to therapies) take on internal psychosocial
significance.
Personal Capacities
Personal capabilities, the proactive abilities acting as drivers and guiders of
behavior, include self-care agency, congruence, and accommodative coping. In the
current model (Figure 1), interactions are indicated by dotted lines between capabilities,
environments, and cognition. Reciprocating arrows along these lines show active and
continuous interactions, all are equally important but some may take precedence based on
a person’s ever changing needs or self-care requisites. Self-care agency is necessary for
development of positive self-care behaviors (Daryasari, Karkezloo, Mohammadnejad,
Vosooghi, & Kagi, 2012; Shreck, Gonzalez, Cohen, & Walker, 2014).
According to Orem’s (2001) foundational work in the 1960s, self-care is a
lifelong process contributing to life, health, and well-being. This process includes

95

characterizing and meeting self-care requisites, making decisions about what can and
should be done, and deliberately performing chosen actions. Agency is the capabilities
and power to perform self-care for survival (Welzel & Inglehart, 2010). The human
ability for engaging in self-care is conditioned by such factors as age, developmental
state, life experience, sociocultural orientation, health, and available resources; including
self-care skills, the valuing of health, knowledge and energy for self-care (Gast et al.,
1989). Further, to engage in deliberate actions a person must have essential powers that
are activated through stimuli.
Accommodative coping is the mechanism or inward behavior of adapting or
adjusting to the stress of insurmountable interference (as in cognitive and physical
impairments) and includes acceptance, cognitive restructuring, and scaling back one’s
goals in response to those impairments (Carver & Connor-Smith, 2010). Morling and
Evered (2006) determined that it is a type of secondary control in which a person aligns
one-self to circumstances in an effort to maintain the perception of control. The
alignment is not resignation to new reality but to set new goals. Morling and Evered
(2006) understood acceptance as enhancing motivation or the capacity to change.
Greenglass and Fiksenbaum (2009) view it not as a reaction to stress but as proactive
coping, involved in goal setting and having efficacious beliefs and associated with
resources for self-improvement, including social support. During cognitive recovery the
patient with stroke accepts their present condition while becoming determined to do what
is necessary to regain lost function. Patients begin to identify practical problems and plan
for possible solutions motivating them to participate more fully with rehabilitation
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(Kirkevold, 2002). The act of adjusting self and accepting the new reality promotes fit
(Morling & Evered, 2006).
Congruence relates to a fit-focused reality. The classical definition of congruence
is an organizational philosophy regarding the consistency or fit between components in
an organization (Nadler & Tushman, 1980). In this concept synthesis the organization is a
person, therefore, congruence guides all decisions about how patient resources and inputs
will be configured to meet demands, constraints, and opportunities within the context of
the person’s reality and history. “Congruence involve(s) pursuing goals for selfdetermined reasons and being oriented toward goals that entail intrinsically satisfying
activity (and) connect with organismic needs” (Sheldon & Kasser, 1995, p. 533). It is the
aligning of all that is within the environments, through the power of personal capabilities
and cognition, in the performance of life. Congruence occurs when patients with stroke
experience personal strivings for genuinely chosen goals that are of intrinsically
satisfying value. The strivings, combined with recognition of satisfying values, help the
patient connect with a desired possible future.
Antecedents
Antecedents are events that must happen or exist prior to the occurrence of a
concept. Four antecedents are identified relating to cognitive recovery. For the purposes
of this synthesis, a person must have experienced an ischemic stroke resulting in
cognitive impairments. It can be expected that a severe ischemic event would leave
cognitive impairments but it has been noted that patients with minor strokes can
experience multiplicative cognitive impairments (Li et al., 2010; Dong et al., 2012).
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The third antecedent is some level of self-awareness after stroke. Self-awareness
is the ability to perceive ourselves objectively while congruently aligning our behavior to
a set of standards and values (Schmidt, Lannin, Fleming, & Ownsworth, 2011). Early
research determined that cognitive therapies can be initiated shortly after stroke even if
self-awareness is limited (Parente & Herrmann, 2003).
Cognitive recovery can occur in a mild pre-existing cognitive disorder because
the goal of recovery is to approach or achieve their pre-injury level of cognitive health.
However, in more severe disorders there may be disruption in self-awareness and ability
to participate in cognitive assessment or therapy. Thus the final antecedent is absence of
significant pre-existing cognitive disorder, i.e. incapacitating dementia, mental illness, or
developmental impairment.
Consequences
The consequences of effective cognitive recovery are improved cognition and a
productive life. A productive life is defined by the patient alone. However, indicators of
successful cognitive recovery can include improved cognitive function (Cicerone et al.,
2008), ability to function in the community (Stephens et al., 2005), and a good quality of
life (QOL) (Edwards, Hahn, Baum, & Dromerick, A., 2006). There is a dearth of research
specifically reflecting the patient-centered cognitive recovery or rehabilitation in stroke
despite support from the American Heart Association (Miller et al., 2010).
Research in comprehensive holistic cognitive rehabilitation therapies (CRT) in
traumatic brain injury offer insight to positive recovery results. Consequences of CRT
include improved community functioning (Geurtsen, van Heugten, Martina, & Geurts,
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2010; Sarajuuri et al., 2005), life satisfaction (Mateer, Sira, & O'Connell, 2005; Svendsen
& Teasdale, 2006; Tiersky et al., 2005), self-efficacy and improvement of cognitive and
emotional symptoms (Cicerone et al., 2008), and improved memory (Mateer et al., 2005).
Research on the psychological aspects of patients with stroke supports use of various
therapies for apathy (Kohno et al., 2010), depression, coping and self-efficacy to
improved QOL (Aben et al., 2008), cognition (Narushima et al., 2014), and verbal
memory and focused attention (Särkämö et al., 2008).
The alternative to effective cognitive recovery is continued cognitive impairment
resulting in poor QOL, possibly dementia and an early death. Approximately 80% of all
stroke survivors with mild cognitive impairment will develop Alzheimer’s disease within
6 years of stroke (Li et al., 2011). Further, patients have a decrease life expectancy if
they develop dementia after stroke (Wiberg et al., 2012); 29-60% shorter than those
without post-stroke cognitive impairments (Oksala et al., 2009).
Model Cases
Walker & Avant (2005) recommend presenting four types of cases (model,
borderline, contrary, and related cases) to clarify a concept and its characteristics. A
model case is a pure exemplar of the concept demonstrating its use while utilizing all of
its defining attributes. The following is an example.
Model case
P.A. experienced a moderate ischemic stroke while at work as a medical
transcriptionist. She was treated promptly but still had significant left hand weakness,
difficulty reading, and slow thinking. She expressed concern over return to work, became
anxious for the future, and stated “I don’t believe people ever get all better after a stroke”.
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P.A.’s care was performed by an interdisciplinary team consisting of a stroke neurologist,
neuropsychologist, stroke specialty nurses, physical and occupational therapists, social
worker, and the recovery case manager (RCM). Within 24 hours of admission P.A. met
with the RCM who coordinated team activities and ensured services were delivered
efficiently. The RCM was a neuroscience nurse practitioner employed by the hospital
system to perform and coordinate care in hospital and as outpatient care provider through
the first few months after the stroke.
At the initial meeting, the RCM identified physical and cognitive needs, namely
impaired working memory and processing speed. P.A. and the RCM identified P.A.s
limitations in her support system and in her health beliefs. P.A. admitted feeling fear,
hopelessness, confusion, and overwhelming panic, making her reluctant to take part in
rehabilitation activities or engage in conversation. Afterward, the RCM met with the care
team, discussed the assessment and considered plan options. At subsequent meetings,
P.A., her family, and the RCM formally identified P.A.’s physical, psychosocial, and
behavioral needs and goals to be achieved.
Also, the RCM counseled P.A. on personal empowerment, decision making and
coping strategies. Plans were initiated during the hospital admission including physical
and occupation therapy, the neuropsychologist assessed and initiated cognitive and
behavioral therapies, and a social worker met with P.A. and her family to discuss
restructuring family dynamics to facilitate recovery. The RCM completed follow up
appointments with P.A and verified treatment by various care providers, including
participation in stroke support group. Meeting with the RCM six weeks after the stroke,
P.A. stated: “I would not have gotten through this without you all. I know I would not be
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able to go back to work and my life would have been horrible. Now I think so much
clearer and I feel like my old self again. I still have work to do getting better but now I
know I can do whatever it takes.”
P.A. experienced a moderate stroke having both physical and cognitive aspects.
Aspects of her internal, external and created environments as well as limitations in her
agency and coping abilities had the potential to hindered her recovery. Her early
cognitive recovery was dependent on a well-organized care process which started with
the patient acknowledging and agreeing on a plan that fit needs, goals and interventions.
Lack of a treatment plan would have resulted in diminished physical therapy, worsening
of psychiatric and cognitive issues, and possible loss of employment.
Borderline Cases
A borderline model case contains most of the defining attributes but differs
substantially in some aspect of them, such as by intensity or length of time (Walker &
Avant, 2005). The following is an example: J.W. experienced a moderate stroke resulting
in mild aphasia, dysarthria, and right hand and leg weakness. The RCM evaluated him
but did not identify any psychosocial or behavioral needs to be addressed, found a strong
agency and adequate coping skills. All stroke symptoms resolved four days after the
stroke and J.W. was discharged with a routine follow up appointment with the stroke
neurologist.
Related Cases
A related case are cases that are in some way related to the concept being studied
but do not contain all of the defining attributes. The following is an example: W.K. has
been diagnosed with schizophrenia and has persistent problems with executive function
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impairment, learned helplessness and social communication skills. W.K.’s psychiatrist
and psychiatric case worker perform psychosocial-behavioral therapies and training,
allowing him to live a stable life in a group home.
Contrary Cases
Lastly, contrary cases are clear examples of cases not related to the concept being
developed. The following is an example: J.J. experienced a severe stroke resulting in
coma for 10 days. He remained disoriented, advancing to incapacitating dementia within
two months. When medically stable, J.J. was transferred to a skilled nursing home for
passive physical therapy.
Conclusion
Although multiple models of cognitive recovery or rehabilitation exist they are
not adequate. The models are hampered by 1) the user’s viewpoint, i.e. the disciplines,
the patient or the care provider, 2) use of loose or 3) confusing terms and 4) the
restrictiveness of the medical model, focusing mainly on healthcare provider activities. A
concept synthesis is inclusive, does not promote one view over the others and brings
various pieces together synergistically. The current concept synthesis re-orders known
information related to patients’ cognitive, psychosocial, behavioral, neurological, and
rehabilitation status. This reordering involves interactions between environments driven
or powered by the patient’s own capabilities resulting in transition to a more stable state.
A patient-centered cognitive recovery model is flexible enough to subsume or support the
other models.
Use of the PCRS model to identify the structure and interactions involved within
cognitive accommodation can promote diverse research. It is anticipated this synthesized
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model will change and grow as interactions between its components undergo empirical
testing. For instance, research is needed to evaluate the importance of each component
and measurement of component influence on recovery outcome. Further questions
include: does a hierarchy of needs effect the transitional state? Can recovery outcome be
consistently predicted? Are indirect indicators like the Neuro-QOL adequate to measure
overall cognitive recovery or is it preferable to measure recovery of each cognitive
impairment? Use of QOL measures present difficulties in regards to the PCRS model.
Neuro-QOL, for instance, measures some aspects of cognition, the physical, internal and
external environments and agency (NINDS, 2010). However, it is not readily apparent if
it measures created environment, acceptance or congruence.
Promoting cognitive recovery is critical in the promotion of health and wellbeing. Despite significant interest and effort on behalf of several health disciplines, at
least 50% of patients continue to be cognitively impaired a decade after stroke (Brainin et
al., 2015). Currently, cognitive therapies focus on adaptation and, to a lesser degree, relearning. While both adaptation and learning are linked to promotion of wellbeing
(Shapira, Barak, & Gal, 2007; Welzel & Inglehart, 2010), it is likely learning would more
useful in attaining the goal of pre-injury level of cognitive health. Early intervention and
knowledge of component prioritization could be linked with interventions and promoting
early relearning.
Cognitive recovery after stroke is a complex concept requiring an
interdisciplinary approach under the leadership of providers well versed in the areas of
treatment and wellbeing. For instance, neuroscience nurse practitioners, trained in both
medical and nursing philosophies, would be uniquely equipped to manage cognitive
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recovery care. The PCRS is a cognitive recovery model flexible enough to subsume or
support the other models facilitating diagnosis, treatment, and the promotion of health
and well-being.
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Abstract
Purpose: To determine the significance and implications of timing in early versus late
intervention on cognitive and motor function following acute brain injury (ABI)
Organizing Construct: Similarities exist between different areas of novel ABI research which
informs on the process of research, as it relates to the significance of timing of interventions and
recovery outcomes.
Methods: Literature pertaining to historic motor impairment research and current cognitive
impairment research were reviewed and analyzed, comparing the process leading up to the, at
that time, novel use of physical therapies after ABI to the ongoing process of cognitive
impairment research.
Findings: Two common themes emerged between early motor and cognitive therapies. The first
was both therapies were considered controversial, costly, possibly ineffective, and possibly
unnecessary due to spontaneous recovery. The second theme was empirical evidence indicating
improved motor and cognitive function when interventions were started within days of ABI.
Conclusions: Motor impairment physical therapies are now standard of care but only after
investigators answered the questions of therapy timing, frequency, and duration. These same
questions plague cognitive research today, therefore, future research should be intensely focused
these questions, specifically on timing.
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Introduction
Currently, ten million Americans live with the consequences of acquired brain injury
(ABI), either from stroke (Go et al., 2014) or traumatic brain injury (Corrigan, Selassie, &
Orman, 2010). In 1960 the U.S. Surgeon General (Burney, 1960) determined that physical
therapy was not routinely or consistently used and called for methods to decrease physical
impairment from ABI. Twenty-six years later, cumulative research had provided solid
therapeutic recommendations for motor impairments, including selecting appropriate patients
and best standards for intensity of therapies, setting and timing, i.e. beginning as soon as possible
after injury (Dombovy, Sandok, & Basford, 1986). These were codified as treatment guidelines
by the World Health Organization (WHO) (1989).
However, cognitive impairment after ABI is just as devastating as physical impairment,
sharing a common result: persistently poor quality of life (Hawthorne, Gruen, & Kaye, 2009;
Nys et al, 2006). Treatment guidelines are intended to improve quality of life, however, there are
no universally accepted cognitive treatment recommendations in acute ABI (Bragge et al., 2014).
The aim of this systematic review is to identify significant common themes between two
research areas, historic motor and current cognitive studies, by comparing findings related to the
timing of interventions, outcomes, and confounders affecting outcomes. This review seeks to
determine the implications of time sensitive interventions and identify knowledge gaps,
suggesting a direction for future cognitive research. The studies were reviewed based on type of
impairment, motor or cognitive, and the results were then combined and examined in the
discussion section.
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Background
The historic motor studies cited in this review were considered novel and significant, by
starting physical therapy relatively early after ABI and involving planned therapy or a formal
Physical Medicine & Rehabilitation consultation (Tobias, Puri, & Sheridan, 1982). Before the
WHO guidelines (1989) a typical treatment trajectory was as follows: medically stabilize the
patient, transfer to a lower level of care or home while they recuperated and then attempt formal
rehabilitation at one to two years post injury (Rusk, Block, & Lowman,1969). There were real
doubts as to the effectiveness of early motor rehabilitation in ABI. Brocklehurst, Andrews,
Richards, & Laycock (1978) noted it was not cost effective because those least likely to recover
were receiving the most long-term and intense therapy. In cognitive rehabilitation, timing rather
than cost is more controversial. Currently, cognitive research frequently starts months or years
after the injury (Lewald, Tegenthoff, Peters, Markus, 2012). Cicerone et al. (2011) noted
cognitive therapy should begin no earlier than the subacute phase because there was not
sufficient data (due to a paucity of study) indicating if recovery is spontaneous or resulting from
interventions. The same lack of available evidence was noted in historic interventional motor
research (MacKay et al., 1992).
Neuroplasticity was the framework used in this review to understand the changes related
to motor and cognitive recovery. The experience-dependent neural plasticity (Kleim & Jones,
2008) supports the pattern of ABI physical and cognitive rehabilitation. Neuroplasticity is the
adaptive capacity of the brain; identified by accelerated axon and dendrite growth, forging of
new brain circuitry, and recruitment of compensatory brain tissue (Dancause et al., 2005;
Murphy & Corbett, 2009). However, brain neural circuits, not stimulated by activity, will begin
to degrade or cortical territory will be taken over by other more competitive brain processes
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(Kleim & Jones, 2008). The activity lasts approximately four weeks and may not be as robust in

the elderly (Murphy & Corbett, 2009). However, it may be possible to extend the window in
some forms of acute injury (Kleim & Jones, 2008), therefore time-to-intervention matters.
Methods
Two searches of the PubMed, OVID Medline, PsychInfo and SCOPUS databases were
executed separately and the results of study selection are presented in Figure 1. One search
comprised ABI motor impairment interventions and a second comprised ABI cognitive
impairments interventions. The strategy for both searches included a series of core and topic
specific search terms (Figure 2). The core terms related to ABI with limited exclusion terms. The
motor impairment search included the core terms and motor therapy related search terms and the
cognitive impairment search included the core terms and cognitive disorder related terms.
In the initial screening titles and abstracts were assessed for relevance. Any ABI study,
involving physical or cognitive interventions, was initially considered. Cognitive studies were
restricted to randomized clinical trials (RCT) as the highest level of evidence (Cicerone et al.,
2000). Due to the paucity of motor RCTs prior to 1985, RCTs and crossover case-controlled
trials (CCT) were allowed. Risk of bias for the individual studies was evaluated using internal
and external study level assessment tools (Hafner, 2008). Information gained from bias
assessment will help characterize study limitations, providing evidence which either strengthens
or weakens conclusions regarding the efficacy of early rehabilitation.
This article will review status of research as it relates to similar therapies for ABI related
motor and cognitive impairment in humans, therefore, studies unrelated to these themes were
excluded. Excluded articles involved non-interventional research (e.g. descriptive studies,
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concept analysis, systematic reviews), technological or pharmacological research, studies outside
the selected time windows, research involving animals or children. Technology based device and
pharmacological research were excluded as they are not yet generalizable to many non-medical
center hospitals; examples include software programs (LoPresti, 2004), virtual reality
simulations (Crosbie et al., 2007) and hyperbaric chamber interventions (Walker, Franke, Cifu,
& Hart, 2014; Wolf, Cifu, Baugh, Carne, & Profenna., 2012).
Included in this review are adult human inpatient ABI interventional studies published in
an English-language, peer-reviewed journal, for motor impairment from January 1, 1975, to
January 1, 1996 and for cognitive impairment from January 1, 2000 to July 7, 2014. These time
windows were selected to compare the initial research in motor interventions to recent research
done in cognitive interventions. Comparing these different periods of research may produce
common themes. The motor studies reflect the period of time when early physical intervention
were controversial (Dombovy et al., 1986; Indredavik et al., 1991); a time before patients with
acute ABI used stroke units or routine physical, occupational, or speech therapy. Therapies for
the late interventional motor group were a hit or miss concept (Dombovy et al., 1986) with little
(Dombovy, Basford, Whisnant, & Bergstralh, 1987; Garraway, Akhtar, Prescott, & Hockey,
1980; Indredavik et al., 1991; Strand et al., 1985) or no therapy while in hospital (Truscott et al.,
1971; Wood-Dauphinee et al., 1984) or after discharge.
The time restriction for cognitive studies captures the beginning of a significant research
proliferation. The older cognitive research (Carter et al., 1983; Hartman et al., 1987; Lincoln et
al., 1984; Lincoln et al., 1985; Rossetti et al., 1998; Rossi, Kheyfets, & Reding,1990; Wiart et
al., 1997) created the foundation for current innovations. Nine cognitive RCTs, between 1975
and 1999, involved interventions that have since become standards of care (Weinberg et al.,
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1977; Ownsworth & McFarland, 1999) or have been expanded upon by later research, described
in this review.
Results
Motor Studies Results
After initial screening, one hundred and seventy-nine motor articles were retrieved and
ten studies (Table 1) met inclusion criteria. The publication dates ranged from 1971 to 1992 with
the majority published in the 1980s (n=7). This reflects the upsurge in early stage rehabilitation
research in the 1980s, with the creation of stroke units, and then decreasing as it became standard
of care in the 1990s. Six motor studies were a retrospective design with a sample size ranging
from 30 to 483 subjects. Three studies were stroke RCTs (Garraway et al., 1980; Indredavik et
al., 1991; Wood-Dauphinee et al., 1984) and one was a prospective non-randomized control trial
(Strand et al., 1985) with moderate sample sizes (N= 126 to 309); only Wood-Dauphinee et al.
(1984) had less than 200 subjects. All of the TBI studies had small samples (N= 35-75). All the
research articles except one (Dombovy et al., 1987) expressed the intent to identify benefits of
early rehabilitation.
Differences in design hindered easy comparison between studies. Four motor studies
(Cope & Hall, 1982; Hayes et al., 1986; MacKay et al., 1992; Tobis, Puri, & Sheridan, 1981) had
small sample sizes (mean: 45 subjects) but enrolled over a four-year time period. It is concerning
that investigators, with such a small catchment of ABI subjects, may not have the opportunity to
perform this research adequately. The outcomes of two of these studies (MacKay et al., 1992;
Tobias et al., 1981) far exceeded the results of all the other motor studies. Equally disturbing is
the lack of adequate descriptions for the physical interventions. Six articles give a very brief
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general description (Table 1) while the other four list the number of overall therapy units but not
the duration or intensity making it impossible to duplicate the studies. A unique problem in the
stroke sample involved subject selection. One article (Garraway et al., 1980) did not define
stroke and two articles defined stroke as either ischemic or hemorrhagic (Dombovy et al., 1987;
Wood-Dauphinee et al., 1984). The remaining studies allowed only ischemic stroke. Three
studies specifically disallowed transient ischemic attacks (Garraway et al., 1980; Indredavik et
al., 1991; Strand et al., 1985) to ensure that early spontaneous recovery would not confound
findings.
The motor studies used descriptive statistics to describe their sample and identify patterns
but were not able to supply evidence beyond their data sets or predict population level patterns.
This unavoidable limitation changed when use of inferential statistics (Nunnally & Bernstein,
1994) became more common in the 1990’s. The descriptive statistics, namely the variables of
length of stay (LOS) and functional independence, indicated early intervention was more
effective than late (Table 1). In the early group subjects LOS was shorter by 50% (Cope & Hall,
1982; MacKay et al., 1992) to 72% (Tobias et al., 1981) and functional status was approximately
50% better in the early group than in the late, in all three TBI studies.
For this review motor studies with planned interventions beginning before 30 days are
considered the early or experimental group and those without inconsistent therapy or therapy
beginning after 30 days are considered the late or control group. Each study defined the early
versus late group slightly differently. Cope & Hall (1982) differentiated their two study groups
by the amount of time from injury to physical therapy (PT), early (mean of 21 days) and late
(mean of 61 days) groups. This aligns with the first four weeks of intensive brain remodeling,
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remaining aware that the longer the time between injury and brain stimulation the less the
neuroplastic changes (Kleim & Jones, 2008).
On the other hand, a hospital based study (MacKay et al., 1992) identified the early group
by participation within 48 hours of injury at one acute hospital’s formalized brain injury
program. The study’s late group had a mean of only 21 days from injury to first PT. However, in
the MacKay et al. (1992) study, PT was inconsistent, ordered at private physicians’ discretion,
and done at ten different hospitals without formalized brain injury programs. As such, it does not
meet the criteria for early and planned stimuli or interventions indicated by Kleim & Jones
(2008). MacKay et al. (1992) reported the early group had decreased mortality and 50% less
length of stay (LOS). Clinically, this was significant as it gives some evidence that organized PT
is as important as timing of therapy. The third TBI study, Tobias et al. (1981) identified three
TBI groups by injury to PT time: onset less than four weeks to PT start, 4-8 weeks, or greater
than eight weeks. But in line with the neuroplasticity window, the review evaluated this as early
(less than four weeks) or late (greater than four weeks).
The seven stroke trials (Dombovy et al., 1987; Garraway et al., 1980; Hayes et al., 1986;
Indredavik et al., 1991; Strand et al., 1985; Truscott et al., 1971; Wood-Dauphinee et al., 1984)
were all located in the acute hospital setting with the main inclusion criteria being time between
symptom onset and therapy. Three studies started PT within 72 hours of stroke onset (Garraway
et al., 1980; Hayes et al., 1986; Truscott et al., 1971) and the remaining studies started PT within
seven days. Treated subjects in these trials received early rehabilitation and late or untreated
subjects received standard of care. Routinely, as many as 41% of patients did not receive any PT
in an acute hospital (Truscott, Kretschmann, Tooke, & Pajak, 1971). Unfortunately, after the
research subjects left the acute setting, data related to any PT received was not presented.
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Similar to the TBI studies, the stroke study results indicated early intervention was more
effective than late. Outcome variables (Table 1) were LOS, mortality, and functional indicators
including final discharge location, Rankin Scale (RS), & activities of daily living (ADLs). For
studies using LOS and discharge location variables (Hayes et al., 1986; Indredavik et al., 1991;
Strand et al., 1985) early group LOS was a statistically shorter and, of clinical significance,
patients were 50% more likely to be discharged directly home. Dombovy et al. (1987) indicated
early group RS was lower (better) at each follow up time point (up to five years post stroke) with
early group rate of improvement at discharge twice that of the late group. However, the
instruments used to measure ADL or RS were not defined and RS reliability and validity
psychometrics where not presented.
Motor Study Bias
Multiple risks of bias in research exist (Pannucci & Wilkins, 2010). The risk of bias,
related to study design, within these early studies must be addressed and two factors should also
be taken into account. First, rehabilitation studies are complicated to design, even today. They
can have multiple confounding variables such as severity of injury, patient age, the use of
different sites for acute and rehabilitation care and the varied rehabilitation needs of the patients.
Second, modern research methods (Bhatt, 2010; Moon, 2009) were relatively young and
statistical methods (Nunnally & Bernstein, 1994), considered common place today, were still
being tried out in the real world of bedside healthcare research.
Examples of risk of bias within the studies, found in each of the motor studies include no
blinded assessments, validation for sample size, or psychometrics for any measurement tool,
analysis limited to descriptive statistics, convenience sampling, retrospective design for six
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studies, and no mention of potential investigator conflict of interest, despite many of the studies
being done in the investigator’s hospital. The RCTs had minimal description of randomization
schemes and two had no explanation of subject washout or high attrition (Strand et al., 1985;
Wood-Dauphinee et al., 1984). Four studies did not indicate initial severity of study population
making it difficult to judge the accuracy of improvement results presented in the articles
(Dombovy et al., 1987; Hayes et al., 1986; Indredavik et al., 1991; Strand et al., 1985). One
study included TIAs and an ill-defined CVD category in the subject population (Truscott et al.,
1971) despite the fact TIAs rarely require inpatient rehabilitation and ill-defined CVD diagnosis
are frequently stroke mimics. No risk of bias across studies was identified. There were fewer
journals in existence at this time and these articles were published in four of them. No articles on
negative results for early physical activity were found but that was not surprising as it is
considered standard of care today.
Cognitive Studies Results
After screening, two hundred and twenty cognitive articles were retrieved, and nine
cognitive articles (Table 2) met inclusion criteria. The publication dates range from 2000 to
2012. Three TBI trials (N= from 12 to 360) and six stroke trials (N= from 11 to 123) have been
included. Two of the TBI trials are RCTs (Fasotti, Kovacs, Eling, & Brouwer, 2000;
Vanderploeg et al., 2008) and one used a form of crossover design (Couillet et al., 2010). All the
stroke trials are RCTs (Akinwuntan et al., 2010; Chen, Hartman, Galarza, & DeLuca, 2012;
Godecke, Hird, Lalor, Rai, & Phillips, 2012; Laska et al., 2011; Nys et al., 2008; Tsang, Sze, &
Fong, 2009). The names of ten cognitive impairments were included as MESH and key word
terms but only five cognitive impairments resulted in appropriate studies: attention, memory,
aphasia, neglect and information processing speed (IPS). Other cognitive impairments were
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evaluated in studies that did not meet the review exclusions, related to study design or device and
pharmacology interventions.
Multiple interventions were evaluated. Two studies for memory impairments used either
a cognitive-didactic training model (Vanderploeg et al., 2008), allowing errors as part of the
process to cognitive self-awareness through learning, or used cognitive task training, requiring
errorless learning (Chen et al., 2012). Two studies evaluated aphasia; Godecke et al. (2012)
addressed the concept of intervention dose by requiring daily aphasia therapy while Laska et al.
(2011) specifically addressed the early versus late timing of interventions. Two studies (Nys et
al., 2008; Tsang et al., 2009) evaluated neglect through the use of low-technology tools
(experimental glasses), believing it can promote neuroplasticity and thus enhance attention.
Akinwuntan et al., (2010) evaluated improve attention and information processing speed (IPS)
via error versus errorless learning rehabilitation models. Fasotti et al. (2000) evaluated improving
IPS impairment via adaptation as well as learning in the intervention, time pressure management
(TPM) (Winkens, Van Heugten, Wade, & Fasotti, 2009).
Only two studies specifically intended to address early versus late cognitive rehabilitation
(Laska et al., 2011; Tsang et al., 2009). Laska et al. (2011) had onset to intervention at a mean of
three days and Tsang et al (2009) had mean of 22 days which is within the neuroplasticity model
time window. Additionally, two other stroke trials, Nys et al. (2008) with mean of nine days and
Godecke et al. (2012) with a median of three days will be considered early intervention studies
for this review. The other studies included in this review have a time range up to 12 weeks. Of
special note are the extended onset time window (at 24 weeks) of two of the TBI cognitive
studies (Couillet et al., 2010; Vanderploeg et al., 2008). Frequently, TBI research time frames
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begin after 24 weeks, based on the literature search. Unlike stroke research, it is not unusual for
TBI studies to begin 5-20 years after injury.
Cognitive Study Bias
There were risks of bias in the cognitive studies, despite investigator efforts. Risk of bias
was assessed on an internal and external study level. A risk does not necessarily mean that the
conclusions of the study should be disregarded as it is nearly impossible to know how much a
bias affected results (Higgins et al., 2011). Most of the articles readily identified the risks and
discussed results in the light of efforts to avoid bias.
All studies used control groups formed by random assignment but the control groups
were not always comparable. In Fasotti et al. (2000) the experimental group was post injury a
mean of 9.8 months (control group mean of 5.3 months). The experimental group would be less
likely to learn, following the concept of brain plasticity. The investigators reported success on
managing time pressure problems (adapting) but not on preventing them, which would require
the ability to learn and plan ahead. The control group in Godecke et al. (2012) was overall
significantly more disabled (p= 0.008). In aphasia training this concern may not be readily
apparent but more disable patients receive increased motor therapy and may experience more
fatigue and depression than lesser disabled stroke survivors. The control group may not have
been able to participate equally in the standard of care speech therapy offered to them. This may
have accounted somewhat for the significant experimental group scores (p= 0.004).
Other risks of bias included unsuitable placebo (Akinwuntan et al., 2010), no blinded
assessments (Akinwuntan et al., 2010; Couillet et al., 2012; Nys et al., 2008; Vanderploeg et al.,
2008), limited psychometric evidence (Akinwuntan et al., 2010; Chen et al., 2012; Laska et al.,
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2011), limited statistical analysis (Tsang et al., 2009; Vanderploeg et al., 2008), and inadequate
sample exclusion criteria. For instance, in Akinwuntan et al. (2010) post hoc analysis, two-third
of the subjects (82% of experimental & 50% of controls) had mild or no cognitive impairment.
Four of the studies calculated effect size (Couillet et al.; 2012; Laska et al., 2011; Tsang et al.,
2009; Vanderploeg et al., 2008) but Tsang et al. (2009) violated the aim of a moderate effect of
0.5 by enrolling 17 subject per group instead of the required 50 per group.
A final internal bias in the articles was a lack of conflict of interest discussion, funding
sources or proprietary status on the therapies or glasses used in the studies. Regarding external
validity for the studies, one study (Laska et al., 2011) did not place its conclusions in context of
existing literature, instead only referred to two studies the investigators themselves had
previously performed. Regarding risk of bias across the studies, it is apparent that there is no
publication bias as both positive and negative study results are published in multiple journals.
This will aid researchers in formulating new studies and extending knowledge.
Discussion
Current and historical research were compared in this review, to identify early and late
group findings related to the timing of the intervention, resulting outcomes and potential
confounders affecting study outcomes, with the intent to determine if interventions are time
dependent. Study outcomes are categorized as early study outcomes versus late study outcomes,
regardless of injury type (TBI or stroke) or impairment (motor or cognitive). In this review,
classification criteria for early (interventional) and late (control) groups depends on
neuroplasticity principles of a time window and intense neural stimuli, as occurs in physical or
cognitive therapy. To qualify, the interventional group must have planned therapy started within
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a time window of 4-12 weeks post injury. Murphy and Corbett, (2009) found the neuroplasticity
window could be extended past four weeks under the condition of increased neural input, such as
physical therapy. The control groups must not have an organized plan of therapy (retrospective
motor studies) or not have therapy designed to affect the impairment (cognitive control groups).
The interventions in all motor studies (Table 1) began within the four-week neuroplasticity
window; most (80%) within seven days of injury, with 50% starting within 72 hours. In these
retrospective studies, the control group were patients undergoing standard brain injury care in
which motor rehabilitation, prior to 1985, it was inconsistent or absent.
There is a paucity of cognitive research in the acute period after brain injury. Therefore,
for the purpose of this review, seven cognitive studies (Table 2) were considered as early or
within the neuroplasticity window: four studies within four weeks and three within 12 weeks
post injury. Two additional TBI studies, considered late studies, were highlighted in the review
to evaluate possible exceptions to the neuroplasticity time window rule. At 24 weeks post injury,
Couillet et al., (2010) evaluated an attention intervention and Vanderploeg et al. (2008) evaluated
memory interventions. All nine cognitive studies had planned interventions and designated
control groups, though one was a cross-over design (Couillet et al., 2010).
Therapeutic interventions in the cognitive studies were primarily designed as learning
interventions. Adaptive training also occurred, in part, in the Fasotti et al. study (2000), an
information processing speed intervention and possibly, to some degree, in the physical therapy
interventions in the motor retrospective studies. Study outcomes provided evidence in support of
early intervention, regardless of injury or impairment type. Early interventions resulted in
improved ADLs (Garraway et al., 1980; Hayes et al., 1986) and improved impairments (Chen et
al., 2012; Godecke et al., 2012; Nys et al., 2008; Tsang et al., 2009). Early group patients (54-
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94%) were more likely to be discharged home rather than institutionalized (Indredavik et al.,
1991; MacKay et al., 1992; Strand et al., 1985), have 50% more strength (Truscott et al., 1971)
and less disability (Dombovy et al., 1987).
Clinical experience indicates improvement of impairments achieved after physical
therapy is sustained, however, there was mixed evidence related to sustained improvement for
the various cognitive impairments. Four studies assessed for sustained change, Godecke et al.
(2012) and Tsang et al. (2009) noted the effect was sustained up to four weeks post intervention
but Chen et al. (2012) and Nys et al. (2008) found no sustained change at 2-4 weeks. One reason
for this observation may be intervention frequency and duration (Nys et al., 2008). The
cognitive studies had a priori intervention parameters, unlike the motor interventions which
based therapy on case-by-case patient requirements (Dombovy et al., 1987).
Unlike the motor studies, some cognitive studies tested for improvement of impairment
and in function (Fasotti et al., 2000; Godecke et al., 2012; Tsang et al., 2009; Vanderploeg et al.,
2008). Tsang et al. (2009) and Vanderploeg et al. (2008), a late study, showed no or limited
functional improvement, respectively. Two early cognitive studies indicated no to little
improvement; possibly due to randomization issues rather than study timing. The negative study
results in Akinwuntan et al. (2010) can be explained by a post hoc analysis indicating more
severe impairment in the control group than interventional group. Laska et al, (2011) had limited
positive main variable improvement but only in one subgroup. A late cognitive study
(Vanderploeg et al., 2008), initiated at 24 weeks after injury, compared two training methods
with the intent to demonstrate improvement in memory as a function in life skills. The study did
indicate that both arms improved life skills but did not supply results specifically demonstrating

ABI: EARLY V. LATE INTERVENTION

130

changes in memory impairment scores. Therefore, other factors in this interdisciplinary inpatient
rehabilitation program may have resulted in improved adaptation rather than neural changes.
A second late cognitive study (Couillet et al., 2010), also initiated 24 weeks after injury,
showed improvement in divided attention due to specific divided attention training; outside of
the neuroplasticity model time frame by at least 12 weeks. There are three possibilities for this
unexpected result. The first and most likely possibility is that the sample size (N= 12) is too
small, increasing the possibility of type I error, i.e. detecting a difference which does not exist.
The second possible explanation is that the crossover study design itself is not suitable for
cognitive studies. Investigators scrupulously attempted to find control procedures which would
not impact the intervention assessment.
However, the brain’s cognitive capabilities and circuitry is still a “black box”. It cannot be
known, for an absolute certainty, that the control tasks did not have some learning impact, a
priming of the pump as is suspected regarding physical activity (Murphy & Corbett, 2009).
Finally, TBI is a unique condition frequently accompanied by an episode of coma and extended,
severe post trauma amnesia. It is not known if different types of injury impact cognitive recovery
differently. It is unlikely that trauma related neuroplasticity is ongoing at that far stage but could
the usual extensive physical rehabilitation be producing brain circuitry that is ripe for cognitive
recover? Literature does support physical exercise’s positive influence on working memory
(Ratey & Loehr, 2011).
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Conclusion
Reducing cognitive impairment after acute ABI will improve the lives of billions of
people worldwide. Nevertheless, early cognitive therapy is controversial today, similar to early
physical therapy decades ago (Dombovy et al.,1986). A more important common theme between
motor and cognitive studies is the empirical evidence showing early intervention results in more
improvement than late intervention. Early motor therapy became standard of care because
research indicated benefit to the patient and informed on therapy type, duration, and frequency.
These few early cognitive studies give indication of patient benefit; perhaps even a glimpse of a
synergistic relationship between motor and cognitive therapy, promoting cognitive recovery as
far out as 24 weeks after injury.
Cognitive recovery is a complex multidimensional area of research. During the flexible
ultra-active neuroplastic window brain changes occur as a result of stimuli, regardless of source,
i.e. from motor or cognitive therapy. More research needs to be built on the framework of
neuroplasticity and potentially other important considerations yet defined. It is critical that
studies are designed carefully and outcomes should be translatable to everyday life situations.
Knowledge gaps range from temporal to practical, including when to start cognitive therapy,
what extends the neuroplastic window and how far can it go, can certain therapies affect multiple
cognitive impairments and what is optimal duration and frequency, how long does cognitive
improvement last and are booster treatments helpful? Almost three decades past from Dr.
Burney’s (1960) call, to decrease in physical impairment, to the passage of the WHO guidelines
(1989). Using their work as a guide, it is past time for an acceleration in early cognitive research.
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Dr. Susan Alderman
UT-H - MS - Neurology
NOTICE OF APPROVAL TO BEGIN RESEARCH

May 23, 2014

HSC-SN-14-0059 - Information Processing Speed Impairment after Stroke, A Descriptive Study
Number of Subjects Approved: Target: 30 /Screen: 40
PROVISIONS: This approval relates to the research to be conducted under the above
referenced title and/or to any associated materials considered by the Committee for the
Protection of Human Subjects, e.g. study documents, informed consent, etc.
APPROVED:

By Expedited Review and Approval

REVIEW DATE:

05/23/2014

APPROVAL DATE:

05/23/2014

EXPIRATION DATE:

04/30/2015

CHAIRPERSON:

John C. Ribble, MD

Subject to any provisions noted above, you may now begin this research.
CHANGES: The principal investigator (PI) must receive approval from the CPHS before initiating
any changes, including those required by the sponsor, which would affect human subjects, e.g.
changes in methods or procedures, numbers or kinds of human subjects, or revisions to the
informed consent document or procedures. The addition of co-investigators must also receive
approval from the CPHS. ALL PROTOCOL REVISIONS MUST BE SUBMITTED TO THE
SPONSOR OF THE RESEARCH.
INFORMED CONSENT DETERMINATION:
Signed Informed Consent Required
INFORMED CONSENT: When Informed consent is required, it must be obtained by the PI or
designee(s), using the format and procedures approved by the CPHS. The PI is responsible to
instruct the designee in the methods approved by the CPHS for the consent process. The
individual obtaining informed consent must also sign the consent document. Please note that only
copies of the stamped approved informed consent form can be used when obtaining consent.
HEALTH INSURANCE PORTABILITY and ACCOUNTABILITY ACT (HIPAA):
HIPAA Authorization required:
HIPAA Authorization within consent form
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Waiver for Screening and Recruitment granted:
Information to be accessed:
Name, address, city, zipcode, telephone number, treatment dates, admission date,
discharge date
Information to be retained:
treatment dates, admission date, discharge date
UNANTICIPATED RISK OR HARM, OR ADVERSE DRUG REACTIONS: The PI will
immediately inform the CPHS of any unanticipated problems involving risks to subjects or others,
of any serious harm to subjects, and of any adverse drug reactions.
RECORDS: The PI will maintain adequate records, including signed consent and HIPAA
documents if required, in a manner that ensures subject confidentiality.
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Dr. Susan Alderman
UT-H - MS - Neurology
NOTICE OF CONTINUING REVIEW APPROVAL

November 11, 2015

HSC-SN-14-0059 - Information Processing Speed Impairment after Stroke, A Descriptive Study
PI: Susan Alderman
PROVISOS: Unless otherwise noted, this approval relates to the research to be conducted under
the above referenced title and/or to any associated materials considered at this meeting, e.g.
study documents, informed consents, etc.
NOTE: If this study meets the federal registration requirements and this is an investigatorinitiated study, or if the PI is the study sponsor or holds the IND/IDE applicable to this study, and
no one else has registered this trial on the national registry, you are required to register this trial
on the national registry at www.clinicaltrials.gov in order to publish results in any of the key peerreviewed journals. For further information write to clinicaltrials@uth.tmc.edu or call 713-5007909.

APPROVED:

By Expedited Review and Approval

REVIEW DATE:

November 10, 2015

APPROVAL DATE:

November 11, 2015

CHAIRPERSON:

John C. Ribble, M.D.

EXPIRATION DATE: 10/31/2016

Upon review, the CPHS finds that this research is being conducted in accord with its guidelines
and with the methods agreed upon by the principal investigator (PI) and approved by the
Committee. This approval, subject to any listed provisions and contingent upon compliance with
the following stipulations, will expire as noted above:
CHANGES: The PI must receive approval from the CPHS before initiating any changes, including
those required by the sponsor, which would affect human subjects, e.g. changes in methods
or procedures, numbers or kinds of human subjects, or revisions to the informed consent document
or procedures. The addition of co-investigators must also receive approval from the CPHS. ALL
PROTOCOL REVISIONS MUST BE SUBMITTED TO THE SPONSOR OF THE RESEARCH.
INFORMED CONSENT: Informed consent must be obtained by the PI or designee(s), using the
format and procedures approved by the CPHS. The PI is responsible to instruct the designee in
the methods approved by the CPHS for the consent process. The individual obtaining informed
consent must also sign the consent document. Please note that only copies of
the
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appropriately dated, stamped approved informed consent form can be used when
obtaining consent.
UNANTICIPATED RISK OR HARM, OR ADVERSE DRUG
REACTIONS:
The PI will
immediately inform the CPHS of any unanticipated problems involving risks to subjects or others,
of any serious harm to subjects, and of any adverse drug reactions.
RECORDS: The PI will maintain adequate records, including signed consent documents if
required, in a manner which ensures subject confidentiality.
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THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER –
HOUSTON
Information Processing Speed Impairment after Stroke, a
Descriptive Study (IPS)
HSC-SN-14-0059

INFORMED CONSENT TO JOIN A RESEARCH
STUDY
INVITATION TO TAKE PART
You are invited to take part in a research project called Information Processing
Speed Impairment after Stroke, a Descriptive Study (IPS), conducted by
Susan Alderman, RN, PhD(c) of the University of Texas Health Science CenterHouston, School of Nursing. For this research project, she will be called the
Principal Investigator or PI. For full disclosure, please know that the PI is
performing this study as part of the PhD program requirement.
You have been invited to join this research study because you have experienced
a mild or moderate acute ischemic stroke. Your decision to take part is
voluntary and you may refuse to take part, or choose to stop from taking part, at
any time. A decision not to take part or to stop being a part of the research
project will not change the services available to you from your physician or
Memorial Hermann Hospital Texas Medical Center. You may refuse to answer
any questions asked or written on any forms. This research project has been
reviewed by the Committee for the Protection of Human Subjects (CPHS) of the
University of Texas Health Science Center at Houston as HSCSN-14-0059.
DESCRIPTION OF RESEARCH:
PURPOSE:
The purpose of this study is to learn if people develop problems with thinking
clearly because they have difficulty processing information after having a stroke.
These problems may be caused by a decreased ability to think quickly, which is
called our information processing speed. When there is a problem with
2/24/16; Ver. 6
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information processing speed we may not always understand how to do tasks,
feel pressured or feel that “things are moving too fast”. We may lose the ability
to quickly think through a task with several steps, like how to drive a car or we
may have trouble following a conversation or watch a TV program. These
problems may be mild or may greatly effects how we get along in life.
The results of this study will help in better understanding how often problems
with information processing speed happen and if they last for several months.
We will also compare the processing speed of people who have routine
rehabilitation with those people who do not have rehabilitation ordered by their
doctor. This will help us understand if rehabilitation for other stroke symptoms
may also help with information processing speed. People who have a mild
stroke and are otherwise qualified to have a MRI will be asked to take part in the
MRI sub-study. Two MRIs will be done after you are discharged from the hospital.
We watch for stroke lesion changes and to see how the changes compare to
changes in your thinking skills.
This is a local study with one location in Houston, Texas. The study will enroll a
total of fifty-six (56) people at this location. The Principal Investigator is paying
for this study through a small research grant. The outpatient MRIs are paid for
by the UT Medical School Department of Neurology.
PROCEDURE:
Six (6) thinking (cognitive) tests for this study will be completed by question and
answer tests for this study, using pencil and paper. There will not be any blood
work. On the last visit we will ask you to complete questionnaires about how
you think your quality of life is at that time. A list of the thinking tests to be done
during each visit can be given to you if you wish. The investigator can explain
them in as much detail as you would like to know.
There will be three study visits; the visit while in hospital, another visit about 3
weeks later and a final visit about 12 weeks from the time you were enrolled in
the study. All together people enrolled in the study will have a total of 3 visits
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over a 12-week time period. Each follow-up visit will last 40-50 minutes and we
will call 1 week prior to verify our appointment with you. In addition to the test
information we will ask about your general health, history of medical problems
and medications, demographic information like race, gender, what was the last
grade of school you attended, about the stroke and any changes you noticed
between visits. You may refuse to answer any questions asked or written on
any forms.
If you agree to take part in the MRI sub-study, a study MRI may will be done
within the next 3 weeks at the UT MRI suite and a follow up MRI will be done at
3 months after the stroke; these MRIs are just like the one you had in the
hospital. The follow up visits may take up to 2 hours; the sub-study MRIs may
take up to 1 hour each and the thinking tests and questionnaires may take 50
minutes. The total time commitment to take part in the study is about 90 days.
SPECIAL CIRCUMSTANCE
One of the baseline cognitive tests, the SDMT, may be completed before the
informed consent process is complete in this study to ensure all participants
meet study criteria. All other study procedures will be performed after informed
consent process has been completed.
TIME COMMITMENT:
The baseline or hospital visit will last about 30 minutes with the PI completing
the study thinking tests. You will also be contacted for 2 follow up visits each
lasting about 40-50 minutes. The participation time will be a total of 3 visits
over three months, starting with the one today in the hospital. If you decide to
take part in the MRI sub-study, we will ask you to return to the UT Medical
School Building within 3 weeks of stroke and after 3 months to have the follow-up
MRI.
BENEFITS:
You may receive no direct benefit from being in this study; however, your taking
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part may help patients get better care in the future.
RISKS AND/OR DISCOMFORTS:
There are no known risks from completing these study tests. If you become tired
during the testing sessions, please let the investigator know and a short rest
break can be arranged. Some of your private health information is gathered for
this study, and there is a risk of loss of confidentiality. Information gathered in
the study will be kept strictly confidential to the full extent of the law.
The MRI scanner uses a large magnet and radio signals to take pictures of your
brain. People who have implants/ pacemakers or who are known to become
afraid in small areas (claustrophobic) should not have an MRI. Claustrophobia
(fear of being in small spaces) may occur during the procedure and the noise of
the machine could be uncomfortable and awkward. We will provide earplugs for
your comfort. The MRI machine may be stopped at any time at your request.
There is no radiation exposure with MRI. There are no known potential longterm risks from frequent MRI. You cannot take part in the MRI sub-study if you
are pregnant. If you get pregnant during the study you must tell the doctor
immediately. You will not be able to continue in the MRI sub-study since
elective MRIs are not approved for pregnant people.
ALTERNATIVES:
The only alternative is not to take part in this study. You can take part in the
study but decline the MRI sub-study.
STUDY WITHDRAWAL:
Taking part in this study is voluntary. You may choose to stop taking part in the
study at any time by notifying the PI, Susan Alderman, at 713-304-7355. Any
data already collected prior to your withdrawal from the study will be included in
the data analysis for the study. The PI may decide to withdraw you from the
study without regard to your wishes. Reasons for this may be a worsening of
your health which may confuse test results or an inability to maintain
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appointments.
IN CASE OF INJURY:
It is unlikely that an injury may occur from the testing sessions or the MRI but
please report any study related injury to the principal investigator (Susan
Alderman, 713- 305-7355) and to the Committee for the Protection of Human
Subjects at (713) 500- 7943.
If you suffer any injury as a result of taking part in this research study, please
understand that nothing has been arranged to provide free treatment of the
injury or any other type of payment. However, all needed facilities, emergency
treatment and professional services will be available to you, just as they are to
the community in general. You will not give up any of your legal rights by signing
this consent form.
COSTS, REIMBURSEMENT, AND COMPENSATION:
All the study related tests done with the Primary Investigator will be provided at
no charge. This does not include the standard of care treatment, such as the
MRI done during your admission, which remains the responsibility of the patient.
The MRIs done as part of the study at the 2 outpatient visits will be paid for by
the study.
If you are selected to take part in the MRI sub-study at 3 weeks and at 3
months, you
will be given $100.00 after the MRI; to cover the parking and travel expenses to
the MRI facility.
If you received a bill that you believe is related to your taking part in this
research study, please contact Susan Alderman at 713-304-7355 with
questions.
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CONFIDENTIALITY:
You will not be personally identified in any reports or publications that may result
from this study. Any demographic and personal information about you that is
gathered during this study will remain confidential to every extent of the law. A
special number will be used to identify you in the study and only the investigator
will know your name. If the investigator will be coming to your home a backup
investigator will be made aware and will have access to your personal
information in case of emergency. There is a separate section in this consent
form that you will be asked to sign which details the use and disclosure of your
protected health information. A signature on the receipt log will be signed for
each follow up visit and kept in a secured area at the University of Texas for the
life of the study and then will be destroyed.

NEW INFORMATION:
Significant new findings developed during the course of the research which
might relate to your willingness to continue participation will be provided to you.
During your Week 12 visit the PI will discuss the results of your participation in
the study and, upon request, will notify you if any manuscripts are published
after the study is completed.
QUESTIONS:
The PI will be glad to answer any further questions at any time. Please contact
the PI to discuss problems, voice concerns, obtain information, and offer input
in addition to asking questions about the research. Please call Susan Alderman
during business hours at 713-304-7355. Include your name and a call-back
phone number.
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AUTHORIZATION TO USE AND DISCLOSE PROTECTED
HEALTH INFORMATION FOR RESEARCH
Patient Name:
Date of birth:
Protocol Number and Title: HSC-SN-14-0059. Information Processing
Speed Impairment after Stroke, A Descriptive Study (IPS)
Principal Investigator: Susan Alderman RN PhD(c)
If you sign this document, you give permission to The University of Texas Health
Science Center at Houston AND/OR Memorial Hermann Healthcare System to
use or disclose (release) your health information that identifies you for the
research study named above.
The health information that we may use or disclose (release) for this research
includes medication list, NIHSS results and the type of stroke you have
experienced. The information disclosed will not contain any identifying
information.
The health information listed above may be used by and/or disclosed (released)
to researchers and their staff. The researchers may disclose information to
employees at The University of Texas Health Science Center at Houston
AND/OR Memorial Hermann Healthcare System for the purposes of verifying
research records.
The researchers may also disclose information to the following entities: UT
School of Nursing Faculty Advisor and other faculty members
The University of Texas Health Science Center at Houston AND/OR Memorial
Hermann Healthcare System is required by law to protect your health
information. By signing this document, you authorize The University of Texas
Health Science Center at Houston AND/OR Memorial Hermann Healthcare
System to use and/or disclose (release) your health information for this
research. Those persons who receive your
health information may not be required by Federal privacy laws (such as the
Privacy Rule) to protect it and may share your child’s information with others
without your permission, if permitted by laws governing them.
If all information that does or can identify you is removed from your health
information, the remaining information will no longer be subject to this
authorization and may be used or disclosed for other purposes. No publication
or public presentation about the research described above will reveal your
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identity without another authorization from you.
Please note that health information used and disclosed may include information
relating to HIV infection; treatment for or history of drug or alcohol abuse; or
mental or behavioral health or psychiatric care. In case of an adverse event
related to or resulting from taking part in this study, you give permission to the
researchers involved in this research to access test, treatment and outcome
information related to the adverse event from the treating facility.
Please note that you do not have to sign this Authorization, but if you do not, you
may not participate in this research study. University of Texas Health Science
Center AND/OR Memorial Hermann Healthcare System may not withhold
treatment or refuse treating you if you do not sign this Authorization.
You may change your mind and revoke (take back) this Authorization at any
time. Even if you revoke this Authorization, researchers may still use or disclose
health information they already have obtained as necessary to maintain the
integrity or reliability of the current research. To revoke this Authorization, you
must call or write to:
Susan Alderman, RN
The University of Texas Health Science
Center at Houston School of Nursing
713-304-7355

Privacy Officer
Memorial Hermann Healthcare
System
909 Frostwood
Texas 77074
Fax: 713-338-4542

This Authorization will expire 6 years after the end of the study.
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SIGNATURES
Sign below only if you understand the information given to you about the research
and you choose to take part. Make sure that any questions have been answered and
that you understand the study. If you have any questions or concerns about your
rights as a research subject, call the Committee for the Protection of Human Subjects
at (713) 500-7943. You may also call the Committee if you wish to discuss problems,
concerns, and questions; obtain information about the research; and offer input about
current or past participation in a research study. If you decide to take part in this
research study, a copy of this signed consent form will be given to you.

For the MRI sub-study: please initial
I agree to take part in the MRI sub-study.

Printed Name of Subject
Time

Signature of Subject

Date and

Printed Name of Legally
Authorized Representative

Signature of Legally
Authorized Representative

Date and Time

Relationship to Subject

Printed Name of
Person Obtaining Consent

Signature of
Person Obtaining Consent

Date and Time

CPHS STATEMENT: This study (HSC-SN-14-0059) has been reviewed by the
Committee for the Protection of Human Subjects (CPHS) of the University of Texas
Health Science Center at Houston. For any questions about research subject's rights,
to report a research-related injury, call the CPHS at (713) 500-7943.
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Information Processing Speed Impairment after Stroke,
A Descriptive Study (IPS) HSC-SN-14-0059

Section 1 - BASELINE
Table of Contents
1.
2.
3.
4.
5.
6.
7.
8.

Demographics
Inclusion & Exclusion Criteria
Presentation Data
Medical History
NIHSS
BI
mRS
Cognitive Tests
a. CVLT II
b. DIGIT SPANSDMT
c. DIGIT SYMBOL-CODING
d. SYMBOL SEARCH
e. MoCA
9. Vital signs
10. Concomitant Medications
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Information Processing Speed Impairment after Stroke,
A Descriptive Study (IPS) HSC-SN-14-0059

Section 2 – WEEK 3
Table of Contents
1.
2.
3.
4.
5.

Presentation Data
NIHSS
BI
mRS
Cognitive Tests
a. CVLT II
b. DIGIT SPANSDMT
c. DIGIT SYMBOL-CODING
d. SYMBOL SEARCH
e. MoCA
6. Concomitant Medications
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Section 3 – WEEK 12
Table of Contents
1.
2.
3.
4.
5.

6.
7.
8.
9.

Presentation Data
NIHSS
BI
mRS
Cognitive Tests
a. CVLT II
b. DIGIT SPANSDMT
c. DIGIT SYMBOL-CODING
d. SYMBOL SEARCH
e. MoCA
SS-QOL
NEURO-QOL
Concomitant Medications
investigator’s SIGNATURE PAGE
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Information Processing Speed Impairment after Stroke,
A Descriptive Study (IPS) HSC-SN-14-0059
Baseline Demographics
1. Age
| | | years
2. Gender
Male

Female

3. Years of
education
5. Race

6. Ethnicity

Asian
Pacific Islander
Black
White
Native American
Hispanic
Not Hispanic

Visit #
7.

Baseline Date

8.

Baseline Time

9.

Week 3 Date
(+/-3 days)
Week 3 Time
(+/-3 days)
Week 12 Date
(+/-7 days)
Week 12 Time
(+/-7 days)

10.
11.
12.

Completed by:

Date
Rang
e

Actua
l Date

Date Completed: | |__| | | |-| |__|
2. Demographics
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Information Processing Speed Impairment after Stroke,
A Descriptive Study (IPS) HSC-SN-14-0059
Inclusion Criteria
Must be all YES to be eligible.
Yes
No
1. Age ≥ 18 and < 80 years old


2. Right hemisphere NIHSS < 10, left hemisphere NIHSS < 12


3. Clinical diagnosis of AIS identified by clinical exam, CT or MRI


4. Abnormal screening SDMT scores are less than:


a. Male Written: 51
b. Male Oral: 61
c. Female Written: 54
d. Female Oral: 62

Exclusion Criteria
Must be all NO to be eligible.
Yes




No




















1. NIHSS 1a (Level of Consciousness) > 0
2. Unable to complete follow up visits
3. Presence or history of any prior central neurological illness or disorder
which might confound training or testing (Ex: such as primary or metastatic
brain tumor, inflammatory or infectious neurological diseases, traumatic brain
injury, known neurodegenerative disorder including Parkinson’s disease).
4. Prior diagnosis of any degree of cognitive impairment (prior stroke is
allowed if patient or legal representative confirms there were no memory or
thinking sequelae).
5. Any significant psychiatric disorder that could be reasonably expected to
affect cognition. (Severe depression, schizophrenia, etc.)
6. Current use of antidepressants, antipsychotics or mood stabilizers
7. Known drug or alcohol abuse or a positive drug screen
8. Any acute or chronic condition that the investigator feels would
significantly impair the subject’s ability to complete the cognitive assessments
or perform the study activities including, but not limited to:
 Blindness
 Inability to comprehend instructions
 Inability to converse in English language with ease (dysarthria and mild
aphasia allowed).

Completed by:

Date Completed: | |__| | | |-| |__|
1
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Presentation Data
1. Date of Onset:
2. Time of Onset:
3. Date of Arrival:

| | | - |__| |-| |__|
( m m -d d- y y)
| | |:| | |
( 0000-2359)
| | | - |__| |-|

|__|

( m m -d d- y y)

4. Time of Arrival:

5. Date of Consent:

| | |:| |
( 0000-2359)

|

| | | - |__| |-|

|__|

( m m -d d- y y)

6. Time of Consent:

| | |:| |
( 0000-2359)

|

3. Baseline MRI/CT
results:

4. Diagnosis:

Completed by:

Date Completed: | |__| | | |-| |__|
4. PRESENTATION DATA
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Information Processing Speed Impairment after Stroke,
A Descriptive Study (IPS)
HSC-SN-14-0059

STUDY ID:

| |__|

Medical History
1. Neuropsychiatric Disease
No
Yes, Specify:
Unknown

8. Peripheral Vascular Disease
No
Yes, Specify:
Unknown

2. CNS Disease (including prior stroke or TIA)
No
Yes, Specify:
Unknown

9. Renal Disease
No
Yes, Specify:
Unknown

3. Cardiac Arrhythmias
No
Yes, Specify:
Unknown

10. Hepatic Disease
No
Yes, Specify:
Unknown

4. Coronary Artery Disease
No
Yes, Specify:
Unknown

11. Hypertension
No
Yes, Specify:
Unknown

5. Other Cardiac Disease
No
Yes, Specify:
Unknown

12. Lung Disease
No
Yes, Specify:
Unknown

6. Congestive Heart Failure
No
Yes, Specify:
Unknown

13. Allergies
No
Yes, Specify:
Unknown

7. Diabetes
No
Yes, Specify:
Unknown

14. Hematological Disease
No
Yes, Specify:
Unknown

Completed by:

Date Completed: | |__| | | |-| |__|

|
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Information Processing Speed Impairment after Stroke,
A Descriptive Study (IPS)
HSC-SN-14-0059

STUDY ID:

| |__|

Continued
Does Patient have any of the following medical history?
15. Gastrointestinal Disease
19. Other
No
No
Yes, Specify:
Yes
Unknown
Unknown
16. Arthritis

If Other, please describe:

No
Yes, Specify:
Unknown
17. Surgical Procedure(s)
No
Yes, Specify:
Unknown
18. Oral Estrogen used in previous year
No
Yes, Specify:
Unknown

Completed by:

Date Completed: | |__| | | |-| |__|

|
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Information Processing Speed Impairment after Stroke,
A Descriptive Study (IPS)
HSC-SN-14-0059

STUDY
ID:

| |__|

|

NIH STROKE SCALE
1. Time point

Baseline
Week 3 Visit
Week 12 Visit

(Select one)

2.

| | | - |__| |-| | |

( m m-dd-yy)

Date:
3.

| | | - |__| |

(0000-2359)

Time:
Stroke Scale Items

Score

1a

Level of Consciousness (0-3)

|

|

1b

LOC Questions (0-2)

|

|

1c

LOC Commands (0-2)

|

|

2

Best Gaze (0-2)

|

|

3

Visual (0-3)

|

|

4

Facial Palsy (0-3)

|

|

5&6

Motor Arm and Leg
|

|

5b Motor Right Arm (0-4 or UN)

|

|

6a

|

|

6b Motor Right Leg (0-4 or UN)

|

|

7

Limb Ataxia (0-2 or UN)

|

|

8

Sensory (0-2)

|

|

9

Best Language (0-3)

|

|

10

Dysarthria (0-2 or UN)

|

|

11

Extinction and Inattention (formerly Neglect ) (0-2)

|

|

12

TOTAL SCORE

|

|

5a

Motor Left Arm (0-4 or UN)

Motor Left Leg (0-4 or UN)

NAME OF PERSON ADMINISTERING SCALE:

Completed by:

Date Completed: | |__| - | | || | |
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Cognitive Testing Scales
(NIHSS, CVLT II SF, Digit Span, SDMT, Digit Symbol-Coding, Symbol Search,
BI, MoCA, mRS, SS-QOL, Neuro-QOL)
Study Code #
Baseline:

_/

/

Week 3:

/__/

Week 12:

/

/

1. NIHSS
Visit:

Baseline

Week 3

Week 12

Week 3

Week 12

Total
Difference

N/A

2. California Verbal Learning Test:
Visit:

Baseline

4th Trail
z-score
Difference

N/A

Short-Delay
z-score
Difference

N/A

Long-Delay
z-score
Difference

N/A
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3. Digit Span:
Visit:

Baseline

Week 3

Week 12

Week 3

Week 12

Week 3

Week 12

Total
z-score
Difference

N/A

4. Symbol digit modality test:
Visit:

Baseline

Total
z-score
Difference

N/A

Memory test
Difference

N/A

5. Digit Symbol – Coding:
Visit:

Baseline

Total
z-score
Difference

N/A
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6. Symbol Search:
Visit:

Baseline

Week 3

Week 12

Week 3

Week 12

Week 3

Week 12

Total
z-score
Difference

N/A

7. Barthel Index:
Visit:

Baseline

Total
Difference

N/A

8. Montreal Cognitive Assessment:
Visit:

Baseline

Total
z-score
Difference

N/A

9. Modified Rankin Scale:
Visit:

Baseline

Total
Difference

N/A

Week 3

Week 12
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Week 12 Visit Only:
10. SS-QOL: Total:

.

11. Neuro-QOL: Total:

.

o

Applied Cognition-general concerns: Sub-total:

o

Applied Cognition-Executive Function: Sub-total:

o

Positive Affect & Well-Being: Sub-total:

.
.
.

I have reviewed the information in the Case Report Form pertaining to the study

Information Processing Speed Impairment after Stroke, A Descriptive Study (IPS)
HSC-SN-14-0059 and all source documents. I have verified that they accurately
reflect this patient’s data, that the study was conducted according to the
protocol and any amendments, the Declaration of Helsinki and Good Clinical
Practices. The patient or the patient’s representative provided written informed
consent prior to the patient’s participation in the study.

Principal Investigator’s Name
(Printed)

Principal Investigator’s Signature

Date
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STUDY ID:

CONCURRENT MEDICATIONS
#

Completed by:

Medication

Route

Indication

Date Completed: | |__| | | |-| |__|
9. Concurrent MEDICATIONS

178

APPENDIX F
Curriculum Vitae

179
CURRICULUM VITAE
Susan Alderman, MSN, BSN RN

EDUCATION:
University of Texas
Houston, Texas

Pursuing PhD in Nursing

Texas Women’s University
Houston, Texas

2012

MS

Nursing Education

Texas Women’s University
Houston, Texas

2000

BSN

Nursing

Lone Star College
Houston, Texas

1987

ADN

Nursing

PROFESSIONAL POSITIONS:
University of Texas Health Science Center at Houston
School of Nursing
Houston Texas
Primary Investigator IPS Study

2014–current

University of Texas Health Science Center at Houston
McGovern Medical School, Department of Neurology
Houston Texas
Primary Investigator CASTLe Study

2013-2014
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